- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 22.12.2023
- Impfdatum
- 22.07.2022
- Beginn
- 21.10.2023
- Tage bis Beginn
- 456,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Anaemia macrocytic
Atelectasis
Blood creatinine increased
Blood culture negative
Blood gases
Blood lactic acid
Blood loss anaemia
Blood thyroid stimulating hormone increased
Bronchial secretion retention
Computerised tomogram thorax abnormal
Condition aggravated
Haemoglobin decreased
Haemoptysis
Hypothyroidism
COVID-19
Chest X-ray abnormal
Chronic kidney disease
Symptomtext
Assessment and Plan Patient is a 75 y.o. female patient of No, Physician with history of recent admission for AHRF discharged on 10/9, CKD, chronic debility, PE, bipolar disorder presented to Hospital with low hemoglobin, found to be hypoxic, PNA seen on CT, and tested positive for COVID Acute Respiratory Failure with hypoxia suspect 2/2 COVID Chronic hypoxic respiratory failure on 2L baseline COPD with acute exacerbation Covid-19 Virus Infection (vaccinated) Hx of PE Hypoxia on presentation and placed on HFNC. Resolved Afebrile and no leukocytosis. Mild tachypnea. VBG: 7.41/40.5/36. Lactic acid 2.3, repeat WNL CT chest showed bibasilar, L>R atelectasis/consolidation, LLL pneumonia Repeat CXR on 10/26 showed improved aeration of LLL base with residual bibasilar opacities still present Neg strep, legionella, respiratory PCR, sputum culture. BC x2 NGTD MRSA nare positive, unclear clinical significance. Off abx Pulm believes prior de-sat d/t mucus plugging, improved with pulmonary hygiene Wean supplemental O2 as tolerated, goal SpO2- 88-92% Patient on 2L O2, at baseline. Breathing treatments, chest physiotherapy Continue decadron for COVID, switch to PO; 10 day course completed ID consulted, completed remdesivir 10/27 Patient refusing DC back to SNF, will need SW assistance 10/30. No other SNF accepting pt, plan to dc back to SNF today. Medically stable for dc home Acute on chronic macrocytic anemia- stable Hemoptysis, mild- resolved Multifactorial anemia including iron deficiency and CKD Currently on eliquis for PE, held at this time Hemoglobin on admission 6.8, baseline ~ 7-8 S/p 1u pRBC 10/21, repeat Hgb adequate response Monitoring hemoglobin to goal> 7 Team discussed blood products with patient in depth 10/26, agreed for blood if needed Pulm did not believe hemoptysis is contributing to anemia significantly IV Fe x2; transition to PO iron, would benefit from colonoscopy outpatient vs inpatient if further bleeds No signs of hematochezia, melena, will continue PO PPI Will closely monitor for any other signs of overt bleeding Patient not having labs drawn although ordered Elevated troponin, suspect 2/2 demand ischemia in setting of hypoxia, acute blood loss anemia, poor clearance in setting of CKD Chronic HFpEF Continue home bumex to maintain euvolemia CKD stage III/VI- Cr continues to be below baseline Lactic Acidosis on admission- resolved Creatinine on admission 2.38. Baseline creatinine 2.4?2.5 Currently below baseline, 1.7 today Renally dose medication, avoid nephrotoxins Hypothyroidism Last TSH 12.55 on 10/6/2023 Continue home Synthyroid, repeat TSH in 4 to 6 weeks from last Chronic pain Continue Flexeril, gabapentin, tramadol Physical debility Per chart review, patient has been nonambulatory for several months Patient has had several hospitalizations Continue PT OT, dc back to SNF Bipolar disorder Schizoeffective disorder Continue Seroquel 25 mg every morning and 50 mg q. nightly Continue doxepin, Depakote BH consulted for reported suicidal ideation. Has since been cleared from precautions GERD Esophagitis Per chart review from last admission, CT showed mild diffuse circumferential thickening of the esophageal wall which can be associated with an esophagitis or sequelae of chronic GERD EGD from 2016 with ulcers. Continue PPI Obesity class I Body mass index is 32.26 kg/m?. Lifestyle education
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 21.11.2023
- Impfdatum
- 28.07.2022
- Beginn
- 20.10.2023
- Tage bis Beginn
- 449,0
- Dosis
- 4
- Route/Site
- UN / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Fall
Hypoxia
SARS-CoV-2 test positive
Symptomtext
The patient has a history of emphysema. She presented to the ED via EMS from her assisted living facility after an unwitnessed fall on 10/20/23. EMS reports they were called to the facility after the patient was found lying on the ground, unknown how long she was down for. She additionally was found to be hypoxic en route, O2 sats in the 80's on room air. The patient additionally reported she tested positive for COVID the day prior (10/19) however denied any symptoms. Ultimately, the patient was admitted 10/20/23 - 10/30/23 with discharge diagnoses including acute hypoxic respiratory failure and COVID pneumonia, among other diagnoses. During admission, a COVID PCR test was done (10/24) which was also was positive. She required supplemental oxygen during admission, however by discharge she had been on room air for more than 24 hours. Of note, the patient has received the Moderan Monovalent COVID vaccine (given 1/30/21; 3/25/21; 11/17/21; 7/28/22). The Vaccine Route and Vaccine site for the most recent vaccine administered on 7/28/22 is unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 31.10.2023
- Impfdatum
- 27.07.2022
- Beginn
- 03.10.2023
- Tage bis Beginn
- 433,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Aortic dilatation
Blood creatinine increased
Blood loss anaemia
C-reactive protein increased
COVID-19
Cardiac resynchronisation therapy
Chest X-ray abnormal
Cough
Decreased appetite
Dyspnoea
Echocardiogram abnormal
Ejection fraction decreased
Electrocardiogram normal
Faeces discoloured
Glycosylated haemoglobin increased
Haemoglobin decreased
Left ventricular failure
Symptomtext
HMS DISCHARGE SUMMARY -- Hospital Admitted: 10/3/2023 Discharge Date: 10/06/23 PCP Handoff Recommended Outpatient Testing o RFP in 1 week o Close follow-up with PCP and cardiology Results Pending At Discharge o None Clinical Summary Patient is a 85 y.o. male patient of MD with history of CAD, CHF, CVA, DM2, MI, CKD who presented to Hospital with shortness of breath. Acute on Chronic HFrEF Acute hypoxemic respiratory failure , resolved Recent CRT-D pulse-generator replacement Shortness of breath, leg edema Initially required bipap in ED, but now weaned down to RA now Ntprobnp 6,098 Echo (5/2020) EF 30-35% with mild MR, moderate aortic root dilatation Chest x-ray with diffuse airspace opacities more prominent on the right lung compared to the left Obtain CT chest for further evaluation Echo with reduced LVEF of 20-25% Home meds: lasix 40qd, metoprolol, arb, Received 40mg IV lasix in ED, ordered 40mg lasix BID Cardiology consulted, continue IV lasix and place on entresto with metoprolol. Entresto prescribed on discharge with Lasix 40 mg twice daily Close outpatient follow-up with Cardiologist Covid-19 Virus Infection Date of onset of symptoms: states had cough for the past week, decreased appetite Symptoms present on admission: cough, shortness of breath Date of covid positive test: 10/3/2023 Vaccination status: vaccinated Imaging: CXR (10/3) diffuse airspace opacities involving the right lung and to a lesser extent interstitial opacities involving the left lung, findings could be due to pneumonitis right >left CT pending Oxygen requirements on admission: bipap Current oxygen requirements: Weaned from 5 L at bedside to RA, no oxygen needed on home O2 evaluation Medical therapy: steroids Received rocephin/azithromycin in ED, continued for now Consultants following: ID Anticipated special isolation end date: 10/13/2023 Procalcitonin wnl and CRP 27.5 Discharge on dexamethasone to complete total of 10 days of dexamethasone Elevated Troponin Likely due to above and also CRS Trop 162 -- > 156 with negative delta ECG shows paced rhythm, no ischemic changes Monitor on tele CAD Follows with cardiology S/p PCI in 1990's Home meds: clopidrogel, atorvastatin Continued Acute Blood Loss Anemia Patient with melena noted overnight on 10/3, endorses black stools but not tarry in nature with oral iron intake Hemoglobin of 10.7 on presentation, down to 8.9 Continue to trend hemoglobin every 8 hours No indication for PRBC transfusion at this time but transfusion consent signed at bedside on 10/4 in case it is needed GI consulted, continue dexamethasone, start PPI BID, no endoscopy needed while inpatient No repeat melena noted Discharge on Protonix 40 mg daily and outpatient follow-up with GI if needed History of CVA Per patient back in 2009 has some residual visual field deficit and balance issues Home meds: statin, clopidrogel Continued PT/OT following CKD Stage III Follows with Nephrology outpatient Care Baseline Cr ~2.1 Cr 2.19 on admission, stable at 2.1 Home meds: sodium bicarb Continued Avoid nephrotoxins and monitor Commend RFP 1 week after discharge NIDDM2, uncontrolled with hyperglycemia Peripheral neuropathy HbA1c (8/2023) 9.5 Home meds: Increased tresiba to 26 units nightly, novolog SSI, gabapentin Continued gabapentin Essential HTN Home meds: Losartan, amlodipine, metoprolol Continue home metoprolol, amlodipine. Discharged on Entresto and increased Lasix Dementia Home meds: aricept Continued
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 27.07.2023
- Impfdatum
- 02.08.2022
- Beginn
- 18.02.2023
- Tage bis Beginn
- 200,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Symptomtext
ACUTE RESPIRATORY FAILURE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 31.05.2023
- Impfdatum
- 11.08.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 12,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Abnormal sleep-related event
Acute respiratory failure
Hypoventilation
Neuropathy peripheral
Obstructive airways disorder
Respiratory failure
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE SLEEP RELATED HYPOVENTILATION DUE TO LOWER AIRWAYS OBSTRUCTION NEUROPATHY ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 24.05.2023
- Impfdatum
- 09.07.2022
- Beginn
- 25.09.2022
- Tage bis Beginn
- 78,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Chronic respiratory failure
Deep vein thrombosis
Hypotension
Hypoxia
Respiratory failure
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT, UNSPECIFIED VEIN HYPOTENSION CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 07.02.2023
- Impfdatum
- 25.10.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 38,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Asthenia
Bronchitis
COVID-19
Chronic obstructive pulmonary disease
Cough
Dyspnoea
Malaise
SARS-CoV-2 test positive
Symptomtext
Patient seen in the ED on 12/2/22 for weakness. Patient has been feeling ill for the past several days, and on 11/28/22 tested positive for COVID. She does wear 2L home oxygen. She has been getting progressively weaker, and reports cough and shortness of breath. COVID PCR test done in the ED also resulted positive. Ultimately she was admitted 12/2/22 - 12/7/22 for COVID-19 infection, acute bronchitis, acute on chronic respiratory failure, and COPD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 14.01.2023
- Impfdatum
- 07.07.2022
- Beginn
- 17.08.2022
- Tage bis Beginn
- 41,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cerebrovascular accident
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 3,0
- Labordaten
- ER stroke center
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 20.07.2022
- Beginn
- 31.07.2022
- Tage bis Beginn
- 11,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Restlessness
Sudden death
Symptomtext
noted to be very restless all evening, walking the hallways, early morning hours rt noted to have expired in his bed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Sudden death
- Hospital-Tage
- -
- Labordaten
- none - sudden death
- Aktuelle Erkrankungen
- orchiotomy due to Malignant neoplasm of prostate
- Vorgeschichte
- atherosclerotic heart disease of native coronary artery with unspecified angina pectoris, ischemic cardiomyopathy, PVD, hyprlipidemia anxiety, essential hypertension, Mild cognitive impairment of uncertain or unknown etiology
- Andere Medikamente
- Celexa, 10 mg qhs, Aspirin 81 mg daily, coreg 3.125 mg bid, Prilosec 20 mg daily, Lasix 40 mg, daily, potassium chloride 10 meq bid, Flomax 0.4 mg daily, Lisinopril 20 mg daily, Lipitor 20 md qhs, Remeron 15 mg daily
- Allergien
- penicillins
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 20.07.2022
- Beginn
- 07.08.2022
- Tage bis Beginn
- 18,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bradycardia
Death
Hypophagia
Hypotension
Muscle twitching
Respiratory rate increased
Skin discolouration
Symptomtext
gradual decrease in food intake after shot, then on 8/7/22 he appeared to be ashen in color, hypotensive, bradycardia noted, increased respirations. over the next few days this continued as well as muscle twitches in arms and legs, oxygen saturation unable to be obtained, he expired on 8/12/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- none - family chose to keep him comfortable instead of treating aggressively
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- vascular dementia, chronic systolic heart failure, iron deficiency anemia, type 2 diabetes, chronic kidney disease, encephalopathy, essential hypertension, unspecifies cirrhosis of liver
- Andere Medikamente
- Docusate Sodium 100 mg BID, Seroquel 50 mg daily, Melatonin 10 mg qhs, Vitamin D 2000 unit, daily, Norvasc 5 mg daily,
- Allergien
- penicillins
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 10.09.2022
- Impfdatum
- 23.07.2022
- Beginn
- 02.09.2022
- Tage bis Beginn
- 41,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Auscultation
COVID-19
Cardiac stress test abnormal
Disorientation
Echocardiogram
Ejection fraction
Heart rate irregular
SARS-CoV-2 test positive
Symptomtext
MD (Physician) Hospitalist Physician Discharge Summary Patient ID: 72 y.o. Admit Date: 9/2/2022 Discharge Date: 9/5/2022 Discharge Diagnosis: Principal Problem: NSTEMI (non-ST elevated myocardial infarction) Active Problems: PAF (paroxysmal atrial fibrillation) COVID-19 virus detected Dementia without behavioral disturbance Essential hypertension Hospital Course: 72 year old female with dementia was admitted for NSTEMI and testing (+) for Covid-19. Cardiology saw her and stress test showed low risk and TTE showed normal LVEF. She has been ambulating and not hypoxic. She will be discharged home today in stable condition. Follow up with Primary Care Doctor in 5-7 days. Physical Exam on the day of discharge: Last Recorded Vital Signs: Temp: 98 ?F (36.7 ?C) Heart Rate (Monitor): 71 Pulse: 72 BP: 125/67 Respirations: 18 SpO2: 94 % O2 Flow Rate (l/min): 0 l/min General Appearance: no distress Eyes: PERRLA ENT: moist mucus membranes, no adenopathy Lungs: clear to auscultation bilaterally Heart: irregular rate and rhythm Abdomen: soft, non-tender Skin: No rashes or lesions Extremities: full ROM Neuro: disoriented Consults: IP CONSULT TO CARDIOLOGY IP CONSULT TO CARDIOLOGY IP CONSULT TO SOCIAL WORK Significant Diagnostic Studies: Stress test, TTE Operations: none Disposition: Home Discharge Condition: Fair
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 13.07.2022
- Beginn
- 31.07.2022
- Tage bis Beginn
- 18,0
- Dosis
- 3
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory distress syndrome
Atelectasis
COVID-19
Cardiac failure congestive
Cardiomegaly
Chest X-ray abnormal
Condition aggravated
Death
Lung consolidation
Lung opacity
Pleural effusion
Respiratory failure
SARS-CoV-2 test positive
Septic shock
Urinary tract infection
Symptomtext
Discharge Diagnosis: Principal Problem: Severe sepsis Active Problems: UTI (urinary tract infection) Essential hypertension Type 2 diabetes mellitus with stage 2 chronic kidney disease, without long-term current use of insulin Chronic combined systolic and diastolic heart failure HPI: Hospital Course: Patient was admitted with severe septic shock secondary to UTI and covid positive with respiratory failure due to CHF and what appears to be early ards. He was progressed to need for intubation however he was DNR and family was called and agreed to honor his wishes. He was transitioned to comfort care and passed. TOD 1220. Cause of death, septic shock uti, CHF, COVID. Consults: None Significant Diagnostic Studies: Narrative & Impression PROCEDURE INFORMATION: Exam: XR Chest Exam date and time: 7/30/2022 2:06 AM Age: 78 years old Clinical indication: Shortness of breath TECHNIQUE: Imaging protocol: Radiologic exam of the chest. Views: 1 view. COMPARISON: CR XR PORTABLE CHEST 7/15/2022 1:50 PM FINDINGS: Tubes, catheters and devices: Left-sided chest wall pacing device. Lungs: See "Pleural spaces" finding. Pleural spaces: Left basilar opacity, probably combination of pleural effusion and adjacent atelectasis/consolidation. Heart/Mediastinum: Stable enlargement of cardiac silhouette. Bones/joints: Median sternotomy. IMPRESSION IMPRESSION: Left basilar opacity, probably combination of pleural effusion and adjacent atelectasis/consolidation. Recommend imaging follow-up until complete resolution. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED. Disposition: deceased Discharge Condition: deceased Discharge Medications and Orders: Current Discharge Medication List CONTINUE these medications which have NOT CHANGED Details rivaroxaban (XARELTO) 20 mg tablet Take 1 Tablet by mouth Once Daily. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: PAF (paroxysmal atrial fibrillation) melatonin 10 mg Cap Take 1 Capsule by mouth. hydrocortisone 2.5 % lotion Applied to lower legs and hands twice a day sparingly Qty: 240 mL, Refills: 1 Associated Diagnoses: Eczema, unspecified type potassium chloride SA (KLOR-CON) 20 mEq tablet Take 1 Tablet by mouth Daily. Qty: 30 Tablet, Refills: 11 Associated Diagnoses: Hypokalemia simvastatin (ZOCOR) 40 mg tablet Take 1 Tablet by mouth At bedtime. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Pure hypercholesterolemia; Coronary artery disease due to lipid rich plaque furosemide (LASIX) 40 mg tablet Take 1.5 Tabs by mouth Daily. Qty: 145 Tablet, Refills: 3 Associated Diagnoses: Acute on chronic systolic CHF (congestive heart failure) glimepiride (AMARYL) 2 mg tablet Take 1 Tablet by mouth Every morning. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Non-insulin dependent type 2 diabetes mellitus carvediloL (COREG) 12.5 mg tablet Take 1 Tablet by mouth Twice a day. Qty: 180 Tablet, Refills: 3 Associated Diagnoses: Chronic combined systolic and diastolic heart failure; Essential hypertension lisinopriL (PRINIVIL) 20 mg tablet Take 1 Tablet by mouth Daily. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Essential hypertension blood sugar diagnostic (ONETOUCH ULTRA TEST) test strips by Other route Daily. Qty: 50 Strip, Refills: 5 Associated Diagnoses: Type 2 diabetes mellitus with hyperglycemia multivitamin (THERAGRAN) tablet Take 1 Tab by mouth Daily. Qty: 30 Tab, Refills: 0 Associated Diagnoses: Ventricular tachycardia aspirin (ASPIRIN) 325 mg tablet Take 1 Tab by mouth Daily. Qty: 60 Tab, Refills: 5
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 13.07.2022
- Beginn
- 31.07.2022
- Tage bis Beginn
- 18,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory distress syndrome
Atelectasis
COVID-19
Cardiac failure congestive
Cardiomegaly
Chest X-ray abnormal
Condition aggravated
Death
Lung consolidation
Lung opacity
Pleural effusion
Respiratory failure
SARS-CoV-2 test positive
Septic shock
Urinary tract infection
Symptomtext
Discharge Diagnosis: Principal Problem: Severe sepsis Active Problems: UTI (urinary tract infection) Essential hypertension Type 2 diabetes mellitus with stage 2 chronic kidney disease, without long-term current use of insulin Chronic combined systolic and diastolic heart failure HPI: Hospital Course: Patient was admitted with severe septic shock secondary to UTI and covid positive with respiratory failure due to CHF and what appears to be early ards. He was progressed to need for intubation however he was DNR and family was called and agreed to honor his wishes. He was transitioned to comfort care and passed. TOD 1220. Cause of death, septic shock uti, CHF, COVID. Consults: None Significant Diagnostic Studies: Narrative & Impression PROCEDURE INFORMATION: Exam: XR Chest Exam date and time: 7/30/2022 2:06 AM Age: 78 years old Clinical indication: Shortness of breath TECHNIQUE: Imaging protocol: Radiologic exam of the chest. Views: 1 view. COMPARISON: CR XR PORTABLE CHEST 7/15/2022 1:50 PM FINDINGS: Tubes, catheters and devices: Left-sided chest wall pacing device. Lungs: See "Pleural spaces" finding. Pleural spaces: Left basilar opacity, probably combination of pleural effusion and adjacent atelectasis/consolidation. Heart/Mediastinum: Stable enlargement of cardiac silhouette. Bones/joints: Median sternotomy. IMPRESSION IMPRESSION: Left basilar opacity, probably combination of pleural effusion and adjacent atelectasis/consolidation. Recommend imaging follow-up until complete resolution. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED. Disposition: deceased Discharge Condition: deceased Discharge Medications and Orders: Current Discharge Medication List CONTINUE these medications which have NOT CHANGED Details rivaroxaban (XARELTO) 20 mg tablet Take 1 Tablet by mouth Once Daily. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: PAF (paroxysmal atrial fibrillation) melatonin 10 mg Cap Take 1 Capsule by mouth. hydrocortisone 2.5 % lotion Applied to lower legs and hands twice a day sparingly Qty: 240 mL, Refills: 1 Associated Diagnoses: Eczema, unspecified type potassium chloride SA (KLOR-CON) 20 mEq tablet Take 1 Tablet by mouth Daily. Qty: 30 Tablet, Refills: 11 Associated Diagnoses: Hypokalemia simvastatin (ZOCOR) 40 mg tablet Take 1 Tablet by mouth At bedtime. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Pure hypercholesterolemia; Coronary artery disease due to lipid rich plaque furosemide (LASIX) 40 mg tablet Take 1.5 Tabs by mouth Daily. Qty: 145 Tablet, Refills: 3 Associated Diagnoses: Acute on chronic systolic CHF (congestive heart failure) glimepiride (AMARYL) 2 mg tablet Take 1 Tablet by mouth Every morning. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Non-insulin dependent type 2 diabetes mellitus carvediloL (COREG) 12.5 mg tablet Take 1 Tablet by mouth Twice a day. Qty: 180 Tablet, Refills: 3 Associated Diagnoses: Chronic combined systolic and diastolic heart failure; Essential hypertension lisinopriL (PRINIVIL) 20 mg tablet Take 1 Tablet by mouth Daily. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Essential hypertension blood sugar diagnostic (ONETOUCH ULTRA TEST) test strips by Other route Daily. Qty: 50 Strip, Refills: 5 Associated Diagnoses: Type 2 diabetes mellitus with hyperglycemia multivitamin (THERAGRAN) tablet Take 1 Tab by mouth Daily. Qty: 30 Tab, Refills: 0 Associated Diagnoses: Ventricular tachycardia aspirin (ASPIRIN) 325 mg tablet Take 1 Tab by mouth Daily. Qty: 60 Tab, Refills: 5
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Anticoagulant therapy
Coronary arterial stent insertion
Coronary artery occlusion
Heart rate increased
Insomnia
Laboratory test
Malaise
Myocardial infarction
Symptomtext
16 hours after injection, Heart Attack, 100% blockage of LAD. Outcome was stent placement, extent of heart damage tbd. Overnight Hospitalization, IV fluids, Blood thinners, Beta Blockers started Historically, with the first 3 shots, little to no sleep for 1 night, heart rate at 10-15 BPM higher consistently for the first day even at rest. General malaise for 1 day, followed by no further symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- 1,0
- Labordaten
- Tests done at hospital not directed at the vaccine, but heart condition
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hypothyroidism, Heart disease
- Andere Medikamente
- Levothyroxine, Valacyclovir, Centrum Mens Multivitamin, B12
- Allergien
- Penicillin, atorvastatin Gluten, Almonds, Lamb Dust, pollen. cats, to a lesser degree
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 23.09.2022
- Impfdatum
- 23.07.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 10,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood pressure decreased
Catheterisation cardiac normal
Chest X-ray abnormal
Computerised tomogram
Dyspnoea
Endotracheal intubation
Feeling cold
Haemoglobin decreased
Intensive care
Loss of consciousness
Mechanical ventilation
Respiratory tract congestion
Scan with contrast
Tremor
Symptomtext
Entered hospital for cardiac catheterization. Completed successfully with excellent report that heart had no blockages. While in recovery, he became cold and began shaking uncontrollably. Started complaining he could not breathe and lost consciousness. Portable Chest xray showed large amount of fluid/congestion. Fall in blood pressure. Required intubation and placed on respirator. Difficulty in maintaining blood pressure. Transferred to Intensive Care Unit and remained on oxygen and respiration assist for almost 24 hours. Given large intervenous doses of steroids and stabilize blood pressure. Was it contrast? was it vaccine? No problem with contrast in past -- had CT with contrast 06/09/2022 with no problem
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 3,0
- Labordaten
- Persistent low hemoglobin -- not responsive to Fe supplements
- Aktuelle Erkrankungen
- External Otitis with cyst
- Vorgeschichte
- Cardiac dysrhymia Hypertension
- Andere Medikamente
- Cardura 4mg Topral 25mg Asprin 80mg baking soda 1/4 tsp
- Allergien
- Penicillin (rash) Azithromycin (rapid, irregular heart beat/side effect?)
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 18.09.2022
- Impfdatum
- 08.07.2022
- Beginn
- 10.09.2022
- Tage bis Beginn
- 64,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Body temperature increased
Communication disorder
Computerised tomogram head abnormal
Electroencephalogram normal
Endotracheal intubation
Fall
Intensive care
Loss of consciousness
Movement disorder
Subarachnoid haemorrhage
Ultrasound Doppler normal
Unresponsive to stimuli
Symptomtext
Patient had a fall with Loss of Consciousness. Head CT showed bilateral subarrachnoid hemorrhage. Transferred to neuro critical care. Repeat stability head scans showed worsening bleed. Patient intubated on day 2 for airway protection. EEG negative for seizures. Elevated temps with no known source of infection yet. Duplex upper and lower extremities (negative). Patient unable to communicate, follow commands or move upper extremities or lower extremities purposefully.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- A-fib (on coumadin), CAD, CHF, DM2, HTN, Parkinson's and neuropathy
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Amiodarone and Spironalactone
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 17.08.2022
- Impfdatum
- 14.07.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 22,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cardiovascular symptom
Syncope
Symptomtext
presented with syncope and covid, had no acute pulmonary findings, pts cardiac symptoms monitored and d/c home
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hypertension, dyslipidemia, GERD, BPH, allergic rhinitis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 01.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Malaise
Paralysis
Symptomtext
She felt sick later in the evening, felt like paralysed and tired. She couldn't do anything for 2 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paralysis
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 28.07.2022
- Impfdatum
- 22.07.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anxiety
Dizziness
Eye movement disorder
Feeling abnormal
Flushing
Gait disturbance
Haemorrhage
Hyperhidrosis
Injection site bruising
Injection site haematoma
Injection site swelling
Nausea
Product administered at inappropriate site
Syncope
Unresponsive to stimuli
Symptomtext
Site: Bruising at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: pt's eyes rolled back in head, went limp, fainted-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Medium, Additional Details: Pt is very phobic concerning shorts, high anxiety, I accidentally hit a vein when giving shot, applied pressure to stop bleeding & applied cold pack for swelling - hematoma at site of inj. when pt started to feel worse, called ambulance and when pt fainted, layed her on floor and put feet up and pillow under head, by time ambulance arrived, pt coming around, talking, squeezed my hand, they checked all vitals and all good
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 26.07.2022
- Beginn
- 26.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Symptomtext
The patient fainted about 5 minutes after receiving the shot. She was out for about 30-45 seconds and was feeling fine afterwards. Had a snack and juice to drink. She was monitored for about 30 minutes and was fine when she left with her friend.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anaphylactic reaction
Dyspnoea
Injection site pain
Syncope
Unresponsive to stimuli
Vomiting
Symptomtext
Site: Pain at Injection Site-Mild, Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Vomiting-Severe
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 02.07.2022
- Beginn
- 13.04.2023
- Tage bis Beginn
- 285,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood pressure abnormal
Hypophagia
Hypotension
Unresponsive to stimuli
Symptomtext
Patient arrived to the local ER with complaints of blood pressure problems from the facility. Patient was hypotensive and unresponsive. Poor po intake at the facility and scheduled for a PEG tube placement on 4-18-23.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Coronary arteriosclerosis, GERD, Depression, Anxiety, COPD, Idiopathic osteoarthritis, CHF, Hypertension
- Andere Medikamente
- Acetaminophen 650 mg po q 4 hours prn Albuterol 2.5 mg/ 3ml nebulizer q 6 hours prn Arginaid packet BID Ascorbic Acid 500 mg po daily Aspirin 81 mg po daily Baclofen 10 mg po q 8 hours prn
- Allergien
- Ampicillin, Bactrim, Doxycycline, Erythromycin, IV dye, Latex, Penicillins, Tetracycline, Ultram
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 23.01.2023
- Impfdatum
- 23.07.2022
- Beginn
- 30.07.2022
- Tage bis Beginn
- 7,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthritis
Computerised tomogram abnormal
Condition aggravated
High frequency ablation
Sleep disorder
Symptomtext
I had been having some trouble with my arthritis, but within a week or two of receiving my third dose of Moderna, everything got much worse. I started treating with some physical therapy actually before my third dose and that wasn't doing anything. I received a cortisone shot which helped a bit. I received a second one and that didn't help at all. I had a procedure done called an ablation, which also didn't seem to help. It's gotten to the point now, where I'm having trouble even sleeping through the night.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- 2022 - CT Scan - Confirmed Arthritis
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- COPD
- Andere Medikamente
- Vitamin D3; Valsartan; Levothyroxine; Sertraline; Rosuvastatin
- Allergien
- None
- Vorherige Impfungen
- October 2021 - Pfizer - Chills, fever, fatigue.
- Staat
- TX
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 16.07.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- 16,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Atrial fibrillation
Blood test
Cardiac murmur
Condition aggravated
Echocardiogram abnormal
Electrocardiogram abnormal
Fatigue
Feeling abnormal
Rhinorrhoea
Symptomtext
08/01/22 that morning I felt so out of sorts. I had no energy and unusually tired. I had a little bit of a runny nose. I went to my doctor. They checked me out and felt like I had a heart murmur and told me I needed to see my cardiologist. A few days later I went to my cardiologist who diagnosed me with AFIB. I had AFIB about 20 years ago that was corrected, and I have had no issues until this. My doctor gave me amiodarone which I started taking that day. This helped. I continue to monitor it with doctor visits. If it acts up again, he will shock my heart. I have recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- EKG, AFIB; Echocardiogram, AFIB; blood work, unsure of results.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes Type 2; High Blood Pressure; AFIB
- Andere Medikamente
- JANUMET; JARDIANCE; ELIQUIS; ZIAC; olmesartan; levothyroxine; multivitamin
- Allergien
- DEMEROL; lisinopril; penicillin; horseradish; seasonal allergies
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 30.09.2022
- Impfdatum
- 02.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anger
Chills
Ejaculation disorder
Hypoaesthesia
Palpitations
Panic reaction
Pyrexia
Symptomtext
Client states the first day had moderate to severe panic with heart racing for 2 days and came back on 8th day. Body became completely numb for 2-3 days during the first week and couldn't feel anything. Client states had normal symptoms of fever, chills, "anger outburst that was severe on the 22nd at 1030" lasted for 4 days. Client states has not been able to ejaculate since receiving the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- referred to urologist due to inability to ejaculate by physician
- Aktuelle Erkrankungen
- UTI "I had that all my life"
- Vorgeschichte
- PTSD, Over active thyroid, schizophrenia, possible auditory hallucinations
- Andere Medikamente
- None
- Allergien
- Abilify, Seroquel, Topamax
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 21.09.2022
- Impfdatum
- 10.08.2022
- Beginn
- 17.08.2022
- Tage bis Beginn
- 7,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Pain in extremity
Paraesthesia
Symptomtext
Patient complained of soreness in L arm. Patient said both arms and hands feel numb and tingle like pins and needles. Patient vital signs 142/84, O2 97% on RA, Pulse 61, R- 20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes
- Andere Medikamente
- Simvastatin Novolog Creon Lisinopril Plavix Gabapentin Albuterol Spiriva Vitamin A Vitamin D Fish oil
- Allergien
- Aspirin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 09.09.2022
- Impfdatum
- 13.07.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 41,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
C-reactive protein decreased
COVID-19
Chest X-ray abnormal
Dyspnoea
Fibrin D dimer
Hypophagia
Hypoxia
Inflammatory marker test
Lung opacity
SARS-CoV-2 test positive
Symptomtext
Patient up to date on COVID vaccinations who admitted with hypoxia and COVID. Provider d/c note: "84 YO female with h/o obesity, CKD3b, ANCA vasculitis, DVT/PE on Xarelto, hypertension, GERD, anxiety/depression, resident of Assisted Living Facility presenting for generalized weakness, acute hypoxia in setting of recent COVID diagnosis. Patient with initial symptoms on 8/21 and tested positive for COVID at facility on 08/22 and was brought in for worsening shortness of breath to the ER where she was found to be hypoxic down to 88% when trying to sit her up although otherwise was saturating well on room air at rest. Patient x-ray showing mild interstitial opacities bilaterally. Inflammatory studies relatively unremarkable with CRP only 0.8 and D-dimer 190. Patient started on remdesivir and dexamethasone although by 8/24 patient was able to be taken off of oxygen and even with activity able to ambulate around the room without desaturating below 94%. Patient also eating much better and PT and OT recommended the patient can be discharge back to her assisted living facility. Daughter was able to provide transportation back to facility this evening. On discharge sent patient home with 8 more days of dexamethasone 6 mg daily to complete 10 day course. Otherwise no changes to her home medications."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 2,0
- Labordaten
- COVID detected PCR on 08/22/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Essential hypertension, benign ANCA-associated vasculitis (*) Knee osteoarthritis Obesity GERD (gastroesophageal reflux disease) CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (*) GAD (generalized anxiety disorder) Immunocompromised (*) CHF (congestive heart failure) (*) CKD (chronic kidney disease) stage 4, GFR 15-29 ml/min (*) Major depressive disorder, recurrent, moderate (*)
- Andere Medikamente
- -
- Allergien
- No true allergies
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 25.08.2022
- Beginn
- 26.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure measurement
Hypotension
Symptomtext
8/26/2022 hypotension: vitals checked on 8/26/22 at 1PM - BP was 57/43 w/ MAP 48 - given midodrine 10 mg x 1 at 2PM - vitals rechecked at 2:30 PM - BP was 92/56 MAP 68 - vitals rechecked at 3PM - BP was 83/58 MAP 66.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- Previous recorded BP prior to this episode was on 8/3/2022 with BP=117/85 & 132/88.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Severe IDD (possibly related to prematurity); mixed seizure disorder; recurrent UTIs; hypertension; hypothyroidism; dementia/decreased cognitive skills; oropharyngeal dysphagia; positive HCV Ab; osteoporosis; cholelithiasis; left nephrolithiasis.
- Andere Medikamente
- Aspiring; Bisacodyl; OsCalD; Cyproheptadine; Divalproex DR; Lacosamide; Lactulose; Synthroid; Lisinopril; Miralax; Vitamin D.
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 25.08.2022
- Impfdatum
- 31.07.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Balance disorder
Body temperature increased
Contusion
Fall
Gait disturbance
Mobility decreased
Nausea
Pain in extremity
Swelling
Tremor
Symptomtext
Pt states she was fine until 11:30 am when she arrived home then arm pain began then she started shaking from head to toe "violently-like you see in a horror movie", then she was sick to her stomach so she proceeded to the bathroom where she fell head first into the bathroom (1st fall), then she got up, turned towards the toilet and fell again where she remained for about 30 minutes. She crawled to her bedroom and she checked her temperature which was 101 degrees F which lowered to 99 F over the course a the next few days. She cooled herself with ice packs but she remained unsteady and could not walk right for nearly a week. The bruise and arm pain persisted for about 3 weeks, Patient reports that she still experiences unsteadiness that persists nearly 1 month post vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Pt reports that she was only seen by her chiropractor for swelling in her neck from the fall about 1-1.5 weeks post vaccination.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Osteoporosis,
- Andere Medikamente
- Levothyroxine, Gabapentin, aspirin
- Allergien
- Penicillin, tetracline, tetanus, codeine, shingles vaccine, flu vaccine
- Vorherige Impfungen
- Childhood vaccines-"highly sick with fevers and doctors to her she couldn't get any shots"
- Staat
- PA
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 20.08.2022
- Impfdatum
- 18.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Injection site pain
Injection site paraesthesia
Joint injury
Symptomtext
Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.). Additional details: Patient had severe pain in shoulder for about 7 days after IM injection. Possible injection into shoulder joint.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 18.08.2022
- Impfdatum
- 27.07.2022
- Beginn
- 31.07.2022
- Tage bis Beginn
- 4,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Activated partial thromboplastin time
C-reactive protein
Full blood count
Headache
Hypoaesthesia
International normalised ratio
Metabolic function test
Migraine
Troponin
Visual impairment
Symptomtext
Patient arrived to our Emergency room here at Medical Center 4 days after receiving his 2nd Booster of the Moderna Covid-19 Immunization. He arrived at the ER with complaints of a headache and numbness in his left arm radiating to his feet. He told the nurse his pain was 5/10 for the headache and that he also had visual disturbances. He has been to the ER with these same complaints previously with the most recent one on 2/26/22 . He says that they are from his Atypical Migraine diagnosis. He had a follow-up on 8/3/22 with his primary care physician after the ER visit to discuss a referral to his neurologist at Clinic who initially diagnosed him with Late Life Atypical Migraines. He had been doing very well for about 2 1/2 years until over the course of the last 6 months he has had now 2 episodes of these headaches with numbness and at this point has had no evidence of any stroke activity.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- CBC CMP CRP INR Troponin APTT all done on 07/31/22 at the ER visit
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Atypical Migraine- Late life Essential hypertension Chronic kidney disease, stage III (moderate) Hyperlipidemia Lentigo Seborrheic keratosis Carcinoma in situ of skin of neck GERD (gastroesophageal reflux disease) Multiple actinic keratoses Primary osteoarthritis of right hip Senile angioma Squamous cell carcinoma of skin Obesity (BMI 30-39.9) Retention of urine Primary osteoarthritis of left hip TIA (transient ischemic attack) Hypokalemia
- Andere Medikamente
- Hydrochlorothiazide 25mg daily Losartan 100mg daily Atorvastatin 10mg daily Verapamil CR 180mg daily Ocuvite-Lutein capsule daily Tart Cherry daily Vitamin C 1000mg daily Aspirin EC 81mg daily Vitamin D3 2000IU daily Colchicine 0.6mg prn fo
- Allergien
- Tape adhesive
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 12.07.2022
- Beginn
- 17.07.2022
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Condition aggravated
Haematuria
Transfusion
Symptomtext
Patient has hx of radiation cystitis with mild hematuria; following vaccination her hematuria dramatically worsened requiring hospitalization and transfusion of blood.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 08.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 07.08.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Anticoagulant therapy
C-reactive protein
Catheterisation cardiac normal
Chest X-ray
Chest pain
Differential white blood cell count
Echocardiogram abnormal
Ejection fraction
Electrocardiogram ST segment elevation
Fibrin D dimer
Full blood count
Magnetic resonance imaging heart
Metabolic function test
Respiratory viral panel
Sleep disorder
Staphylococcus test
Stress cardiomyopathy
Troponin
Symptomtext
He had the onset of chest pain after dinner 8/6. He took ibuprofen and went to bed. No associated dyspnea, dizziness, diaphoresis or nausea. He woke up at 3am and the pain was gone. The pain recurred later in the morning and he presented to the ED. EKG with subtle ST elevation/J point elevation in the inferior and anterior leads. Mild pain in the ED. First troponin 2931. Underwent LHC showing clean coronaries. Started on DAPT with ASA and plavix. Troponins up trending to 5500. Underwent ECHO showing Takotsubo cardiomyopathy with LVEF 40-45%. Started on colchicine 0.6 mg and ibuprofen 600 mg TID. In settign of low EF, started on toprol 25 mg and losartan 25 mg. Will undergo cardiac MRI today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 4,0
- Labordaten
- BMP x2 8/7/22 CRP 8/7/22 Resp pannel 8/7/22 MRSA PCR 8/7/22 CBC w/ diff 8/7/22 CBC 8/7/22 Cardiac troponins x3 8/7/22 D-dimer 8/7/22 Chest X ray 8/7/22 LHC 8/7/22 EKG x 4 8/7/22 ECHO 8/7/22 cardiac MRI 8/8/22
- Aktuelle Erkrankungen
- none, only PMH listed below in item 12
- Vorgeschichte
- Anxiety, depression, ADHD
- Andere Medikamente
- Adderall 15 mg BID, escitalopram 10 mg daily, lamotrigine 100 mg daily
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 06.08.2022
- Impfdatum
- 05.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Fatigue
Pyrexia
Sleep disorder
Tremor
Symptomtext
Patient woke up in the middle of the night with a high fever (patient reported 105 F) and very bad chills and shaking. Patient stated this lasted approximately 5 hours before she was able to get back to sleep. She reported that the fever and chills had resolved by the following morning at 10:00 AM but she was still feeling tired and fatigued.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Atrial flutter
Chest pain
Dizziness
Dyspepsia
Electrocardiogram abnormal
Laboratory test
Pain
Pain in jaw
Pallor
Peripheral coldness
Symptomtext
I administered 0.25 mls of Moderna vaccine at approximately 2:45 pm to patient in the pharmacy. She remained in the pharmacy for 15 minutes for post-vaccination observation. She felt like she was having what she described as "heartburn" and asked my technician for some water while I was counseling another patient. Soon after, she said she had shooting pain radiating from the left side of her chest to the right. She started to complain of jaw pain. I took her blood pressure. It was 150/91. She remained calm and conscious. She continued to talk to me and I repeated her blood pressure and it was 140/93. She became pale in color and her skin was cool to the touch. I called emergency and gave her 4 tablets of chewable Aspirin 81mg. While we waited for the paramedics to arrive, she continued to talk to us but became dizzy. We had her sit on the floor with her back resting on a chair. We continued to monitor her blood pressure. The paramedics arrived and performed an EKG in the ambulance. It came back ABNORMAL ATRIAL FLUTTER. They proceeded to take her to the Emergency Room at Hospital to do lab work and give her a complete assessment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- EKG
- Aktuelle Erkrankungen
- Tachycardia
- Vorgeschichte
- Tachycardia Hypercholesterolemia
- Andere Medikamente
- Atenolol 12.5mg twice daily Atorvastatin
- Allergien
- codeine and hydrocodone
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 18.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Enuresis
Mobility decreased
Pyrexia
Weight decreased
Symptomtext
patient stated that she started having chills and fever 8 hours after the vaccine; she report a temperature of 100.6 she stated that she urinated all night after having the vaccine and lost 3 pounds the day after the vaccine, she reported that her oxygen saturation was 89 and 90 and all she could do was sit all day. she states that normally her saturation is 95. She also reported using her rescue inhaler throughout the day. The day after the vaccine she also stated that her blood pressure top number dropped to 92. She reports that her normal blood pressure is usually 128-130 over 68-70. She stated that the 2nd day after the vaccine she began feeling more normal and she only used her rescue inhaler 1 time.. I spoke to her today 7/27/22 and she stated that she feels back to norma.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- COPD, Pulmonary necrosis, 3rd degree kidney failure, primary biliary cholangitis, hypertension
- Andere Medikamente
- premarin, zaleplon, levothyroxine, chlorthalidone, losartan, bimatoprost eye drops as needed, albuterol in haler as needed
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 20.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Migraine
Rash
Rash erythematous
Rash macular
Rash pruritic
Urticaria
Symptomtext
Red, macular, pruritic rash bilateral lower extremities and bilateral forearms; mild shortness of breath; migraine headache; scattered urticaria like lesions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- No testing done.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hx of lung cancer
- Andere Medikamente
- ASA, Topamax, Lopressor, Wellbutrin, Aldactone
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 13.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Gait inability
Laboratory test abnormal
Tremor
Symptomtext
Received both vaccines and directly afterwards, pt was feeling dizzy and light headed. He started shaking as well and we took his BP, and it is was 81/53. This didn't resolve over a half hour, so the pt asked us to call 911. The paramedics responded after 5 minutes and evaluated the pt. His BP came back up, but he was still feeling dizzy and unable to walk, so he decided to take an ambulance to be on the safe side so that medical professionals could run some more tests to make sure he was okay.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None reported
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 08.12.2023
- Impfdatum
- 27.07.2022
- Beginn
- 07.12.2023
- Tage bis Beginn
- 498,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chills
Headache
Oropharyngeal pain
SARS-CoV-2 test
Symptomtext
Sore throat, chills, headache
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- IDNOW positive 12/07/2023
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 01.05.2023
- Impfdatum
- 28.10.2022
- Beginn
- 22.04.2023
- Tage bis Beginn
- 176,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Oropharyngeal pain
Paranasal sinus hypersecretion
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Sinus congestion
Throat irritation
Symptomtext
I tested positive for COVID-19 on 4/22/23. I had a sore, scratchy throat, fever, congestion, and a cough. I took TYLENOL for the fever and took some cough drops. I contacted my doctor and was prescribed 5 days' worth of PAXLOVID. After finishing PAXLOVID, I had a rebound COVID-19 test. I am still dealing with this at this time. I am having sinus drainage, and congestion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 22APR2023 COVID-19 test, positive; 27APR2023 COVID-19 test, negative; 30APR2023 COVID-19 test, positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Blood Pressure
- Andere Medikamente
- Multivitamin; fish oil; losartan; hydrochlorothiazide
- Allergien
- Seasonal allergies
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 15.02.2023
- Impfdatum
- 16.08.2022
- Beginn
- 16.12.2022
- Tage bis Beginn
- 122,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain upper
COVID-19
Colitis
Exposure to SARS-CoV-2
Feeling abnormal
Gastrointestinal disorder
Medical diet
Pain
SARS-CoV-2 test positive
Surgery
Symptomtext
After the vaccine, I had soreness and just not feeling good for about three days. I was exposed to COVID-19 at the hospital when I had surgery and with my sister. I tested positive for COVID-19 on 12/16/2023. I got a prescription for PAXLOVID. I tolerated the medication, but it tasted terrible and made me nauseated. I had a rebound case of COVID-19 and tested positive again 12/27/2023. From 01/06/2023 to 01/12/2023, I had ongoing gastrointestinal issues. On 01/16/2022 I went to the emergency room because my stomach pain got worse. The emergency room doctor said I had colitis. I was referred to a gastroenterologist and he said I did not have the right symptoms for colitis. I am on a diet to eliminate foods to see if that will help my colon. At this time, they don't know what caused my symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- 16DEC2022 COVID-19 test positive; 27DEC2022 COVID-19 test positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Levothyroxine; pravastatin
- Allergien
- Sulfa; ciprofloxacin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 01.02.2023
- Impfdatum
- 02.08.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 30,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Antinuclear antibody positive
Arthralgia
Laboratory test abnormal
Pain in extremity
Symptomtext
Developed arthritic pain in my hands and feet and right elbow. Also had pain in left foot that lasted for 16 hours then disappeared spontaneously.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Had lab tests done 12/30/22, showed positive ANA and ANA titer 1 was High (value 1:40). ANA pattern 1 was cytoplasmic.
- Aktuelle Erkrankungen
- Stage 3a kidney disease, thyroid disease, Hyperlipidemia
- Vorgeschichte
- Kidney disease stage 3a, Thyroid disease, high cholesterol
- Andere Medikamente
- Levothyroxine 75 mcg, Crestor 40 mg, Calcium 500 mg with vitamin D 400 mg (2x day)
- Allergien
- Allergic to metals, sulfa drugs, prednisone, latex, cough suppressants
- Vorherige Impfungen
- Pfizer
- Staat
- GA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 18.01.2023
- Impfdatum
- 19.07.2022
- Beginn
- 11.11.2022
- Tage bis Beginn
- 115,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Malaise
Productive cough
Respiratory tract congestion
SARS-CoV-2 test negative
Sinusitis
Sputum discoloured
Symptomtext
I did not have an adverse event after receiving the vaccine. I started not feeling well on 11/11/2022, I had congestion and productive cough with a yellow and green color. We had plans to travel so I saw my doctor on 11/12/2022 and again on 11/15/2022. I was tested for COVID-19, and it was negative on 11/15/2022. I was diagnosed with a sinus infection and got the prescription ZITHROMAX.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- 15NOV2022 COVID-19 test negative
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Chronic Kidney Disease; Hypertension
- Andere Medikamente
- N/A
- Allergien
- Ace inhibitors
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 16.07.2022
- Beginn
- 06.10.2022
- Tage bis Beginn
- 82,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Fatigue
Feeling abnormal
Foreign travel
Haemorrhage
Influenza virus test positive
Malaise
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Scab
Sinus disorder
Symptomtext
I awoke feeling moderately well, went to the conference I was there to attend, halfway through the conference I started to feel unwell and left. Once I got back to my room, I tested with a home COVID-19 test that came back positive, I have a fever, congestion with bloody crusting, cough, fatigue. My fever finally broke by day five and I was testing negative by that day also. My wife and I stayed in quarantine the whole time we were overseas for the conference. Once home we tested positive for the flu in December, and I was able to finally able to get relief from the sinus issue. I am still dealing with a fogginess and fatigue since having COVID-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Home COVID-19 test
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Mitral Valve Prolapse
- Andere Medikamente
- BRILINTA; propranolol; CRESTOR
- Allergien
- Aspirin; apricot; PHENERGAN
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 29.12.2022
- Impfdatum
- 14.08.2022
- Beginn
- 23.12.2022
- Tage bis Beginn
- 131,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Arthralgia
COVID-19
Fall
Head injury
SARS-CoV-2 test positive
Symptomtext
Hospitalization: 12/23/2022 - 12/26/2022 Presentation to the ED: fell & hit head. No LOC. Shoulder pain. COVID + date: 12/23/2022 Treatment: no indication for remdisivir or steroid. Discharge to: Home. 002A21A 2/24/2021 017B21A 3/29/2021 014C21A 9/11/2021 006M21A 8/14/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hypertension, hyperlipidemia, GERD, osteoporosis, anxiety/depression, MS, peripheral neuropathy.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 05.11.2022
- Impfdatum
- 20.07.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Hot flush
Symptomtext
Severe hot flashes / chills off + on for about 4 wks. 2nd Booster; Just hot flashes had been reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Vit. D, calcium, Escitalopram 1/2 5 mg
- Allergien
- Benadryl, phenagren
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 19.10.2022
- Impfdatum
- 11.08.2022
- Beginn
- 22.08.2022
- Tage bis Beginn
- 11,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test normal
Discomfort
Rash erythematous
Rash pruritic
Urticaria
Symptomtext
Eleven or 12 days after my 2nd booster with the Moderna COVID-19 vaccine (I had got all my prior 3 COVID-19 vaccines with Moderna as well) I developed red, VERY itchy and uncomfortable rashes all over my hands and feet. They changed location and as the day progressed, I got rashes in my neck, my back, my tummy, my thighs. In the days that followed, I got them even on my thighs, loin area. They were really uncomfortable and VERY itchy. I have now learned (from a dermatologist I saw today) that these are hives or urticaria.... I tried Benadryl and that helped. I thought the rashes would go away in a few days, like the "COVID arm" rashes I got on my arm after the 1st & 2nd COVID vaccine injections, which were delimited to the injected site... But no... this rash arrived to stay. I still have them, now almost for 2 months since they began in mid-August. Thankfully, my PCP suggested Zyrtec, which works well (as Benadryl), but both are sedating for me. And I don't want to take these for weeks as I fear that when I stop them my anxiety/ insomnia may return more vividly as my body gets used to feeling sleepy with these meds. Claritin does NOT work for me. Aside from the urticaria concern, what happened to my body? What hacked my immune system? When will this mast cell/hyper histaminergic state craziness subside? Can I have my annual flu shot? I am afraid of taking even the flu shot, knowing my immune system is in overdrive. I am totally scared of taking another COVID-19 booster shot ANYTIME in the future. What is this side effect? What caused it? How can this be re-set to my normal levels? Should I just refuse any future COVID shots? And the flu shot?
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash erythematous
- Hospital-Tage
- -
- Labordaten
- Many blood tests were taken as part of my annual physical, and also to address my concern with this hives-type symptoms. Results were within normal range. Two PCPs at clinic have reviewed my results and all tests look normal.
- Aktuelle Erkrankungen
- None! I only had the "COVID arm" that developed after my 1st and 2nd shots with the Moderna mRNA vaccine, and a minor COVID arm with 1st Moderna COVID vaccine booster. The covid arm losted for a few days (4 max) and was restricted to the injected arm
- Vorgeschichte
- Anxiety (cause for the Paroxetine 10 mg/day prescription)
- Andere Medikamente
- Centrum multivitamin, Fish oil (1,000 mg Omega-3), Vitamin C, Paroxetine HCl (10 mg/day), Spironolactone (37 mg/day), Minoxidil (topical scalp application, 1/day)
- Allergien
- NONE KNOWN allergies to anything, not to vaccines (and I have had many,: annual flu, Shingrix, yellow fever, Japanese encephalitis, tetanus, etc....), none to anesthetics (local or other), medications, detergents, creams, soaps, perfumes, food (incl .nuts,, seafood, gluten etc.), none to any type of gloves (latex or otherwise- I am a lab scientist by training and used many types for decades)...
- Vorherige Impfungen
- Only COVID arm to the 1st Moderna 3 COVID vaccines
- Staat
- MO
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 26.09.2022
- Impfdatum
- 11.07.2022
- Beginn
- 24.07.2022
- Tage bis Beginn
- 13,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Rash
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- seasonal allergies, ashtma
- Vorgeschichte
- high blood pressure
- Andere Medikamente
- levothyroxine, lisinopri,singulair, omepraxzole, fertraline, oxybutin, hctz
- Allergien
- statins
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 09.09.2022
- Impfdatum
- 04.08.2022
- Beginn
- 17.08.2022
- Tage bis Beginn
- 13,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Computerised tomogram
Eye pain
Gait disturbance
Haemorrhage
Immunisation reaction
Lacrimation increased
Pain
Ultrasound Doppler
X-ray
Symptomtext
She has a distinct abnormality in her left foot; she lifts her foot up as if she's had a stroke. She had hemorrhaging in the left thigh. After receiving her vaccine, she had "COVID-19 arm" and pain for a couple of days. I took her to the hospital and she saw a cornea eye specialist due to constant tearing in her eye and pain. She had 2 CAT scans to rule out possibility of suffering a stroke. She also had a Doppler and x-rays to rule out other conditions. She's been seen by neurologist and other specialists to try to determine a diagnosis of the pain and adverse event she's suffering from. No one from the clinic associated any of her symptoms to the vaccine she received, but she has follow-up appointments for further diagnosis and investigation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye pain
- Hospital-Tage
- -
- Labordaten
- Doppler, CAT Scan, X-Ray
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Type 2 Diabetes; Hypertension; Pacemaker; Coronary Heart Disease; High Cholesterol; Scoliosis; Low Back Pain; Spondylolysis; Muscle Weakness
- Andere Medikamente
- Over 55 Multivitamin; Aspirin; Metformin; Lisinopril; Simvastatin; Hydrocodone; Ezetimibe; Metoprolol-tart; Tradjenta; Latanoprost
- Allergien
- Augmentin; Bactrim
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 02.09.2022
- Impfdatum
- 14.08.2022
- Beginn
- 15.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Symptomtext
Skin rash 1 day after vaccination (8/15/2022 until 8/21/2022).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypothyroid, high blood pressure, reflux
- Andere Medikamente
- Synthroid 112mcg, Crestor 20mg, Metformin ER 500mg, HCTZ 25mg, Potassium 20mEq, Coreg 6.25mg, Protonix 40mg
- Allergien
- Lasix
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 24.08.2022
- Beginn
- 24.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Joint range of motion decreased
Pain in extremity
Peripheral swelling
Tenderness
Symptomtext
She got her vaccine, she did OK initially but slowly that day she began to feel sore at her injection site. That evening is when she felt more pain at the injection site, then slowly traveled through her whole arm. The next she had much more significant pain, lack of ROM, and just real tender the whole arm. She did not notice any redness, the arm felt swollen, but when she looked in the mirror it was not significant swollen, but just has that sensation. The pain has been the primary thing of the entire arm. She can open and close her hand, but today was more limited and the inability to do lateral raise, bicep curls and to move in her normal way. She was not given any medication, she does take OTC Aleve that she took and the medicine she takes for her chronic pain she has been using. She declined taking Tylenol. She has not been seen by the doctor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- URI 1 month prior.
- Vorgeschichte
- Type II diabetes, CHF, asthma, depression, chronic pain, osteoarthritis.
- Andere Medikamente
- Tizanidine 4 mg, Depakote ER 500 mg, Miralax 17 grams powder, Propranolol 120 mg ER capsule, Jardiance 25 mg, Levocetirizine 5 mg, Levoxyl 50 mcg, Rosuvastatin 25 mg, albuterol inhaler 90 mcg, Simbicort inhaler 80/4.5 mcg, Singulair 10 mg,
- Allergien
- Codeine (itching), Gabapentin (aggressive and hostile), Buspirone (hallucinations)..
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 19.08.2022
- Impfdatum
- 19.08.2022
- Beginn
- 19.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Pruritus
Symptomtext
Pt starts to itch all over body. Pt took 2 Benadryl tablets prior to vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Pt took a 2 Benadryl tabs (OTC)
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 11.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood pressure increased
Dizziness
Nausea
Symptomtext
Pt went to the er because of elevated bp , nausease , and dizzy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 10.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Injection site erythema
Injection site nodule
Symptomtext
Large knot under skin where the shot was given, and red circle approximately 1 inch around the area where the shot was given
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Yes, yeast infection & UTI
- Vorgeschichte
- Generalized anxiety, heart palpitations, multiple PVS, Tachycardia, ADHD , anxiety and depression
- Andere Medikamente
- Prescription medications : Dextroamp-Amphetamin 15mg Trintellix 10mg nitrofurantoin 100mg (anabiotic) cyclobenzaprine 5mg metoprolol tartrate 25mg Alprazolam 0.5mg
- Allergien
- Not that i know of
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 09.08.2022
- Impfdatum
- 23.07.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 13,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain lower
Bladder hypertrophy
Blood test
Blood urine present
Computerised tomogram abnormal
Cystitis
Discomfort
Dysuria
Lymphocyte count normal
Monocyte count increased
Neutrophil count increased
Neutrophil percentage increased
Nitrite urine present
Urethritis
Urine analysis abnormal
Urine ketone body present
Urine leukocyte esterase positive
White blood cell count increased
Symptomtext
I started having pelvic area pressure and a little pain at the end of urinating. They diagnosed it as left lower quadrant abdominal pain, infective urethritis, cystitis, and urethritis. They believed that I had a bladder infection and they would know more when the culture sample comes back. They prescribed an antibiotic.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain lower
- Hospital-Tage
- -
- Labordaten
- CT Scan 8/7/22 thickening of bladder wall; Urine sample 8/7/22 infection, Ketones, Urine POC 15 (Small), Blood, Urine POC (Large)+++, Nitrite, Urine POC (Positive) Leukocyte EST (Large)+++; Blood Panel 8/7/22 White Blood Cell Count Elevated, Preliminary ABS NEUT 10.48, Neutrophils 80.5, Lymphocytes 14, Monocytes 4.2, Absolute Neutrophils 10.48
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Blood Pressure
- Andere Medikamente
- Hydrochlorothiazide; vitamin D3; omega 3; magnesium; collagen peptides
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 08.08.2022
- Impfdatum
- 17.07.2022
- Beginn
- 30.07.2022
- Tage bis Beginn
- 13,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test normal
Rash
Symptomtext
I developed a skin rash that seems to shift position depending on time of day. Blood Tests were run to determine if this was an "internal" issue. Results normal. Doctor prescribed antihistamine that helps, but not completely at night.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- Blood tests were run to determine if this was an "internal" issue. Results normal 8/2.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- Finasteride; trazadone; venlafaxine; metronidazole; ibuprofen
- Allergien
- Penicillin; doxycycline; tuna
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 05.08.2022
- Impfdatum
- 18.07.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 4,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Peripheral swelling
Symptomtext
Pain and swelling of left hand 4 days after vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Type 2 DM, CAD, CKD, HTN, hyperlipidemia, AOCD, Barrett's esophagus, GERD, gastroparesis, neurogenic bladder
- Andere Medikamente
- Ozempic, aspirin, Miralax
- Allergien
- Amlodipine, Avelox, Benicar, Ciprofloxacin, Cozaar, insulin, IV dye, Lipitor, Lopid, Metoprolol succinate, Neurontin, Nexium, Norvasc, prednisone, Synvisc, Tricor, Vascepa, Verapamil, Zestril, Zocor, Zyrtec
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 04.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 04.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site bruising
Injection site swelling
Pain in extremity
Symptomtext
Received 2nd booster - patient came in and reported extreme bruising and swelling at injection site (about 2-3 inches in diameter) patient also reported pain in lower limbs that improved with walking. She said she would go to the ER/seek help if she noticed any bruising in her legs as she had not yet checked when she reported to the pharmacy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ASPIRIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 03.08.2022
- Impfdatum
- 27.07.2022
- Beginn
- 30.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site erythema
Pain in extremity
Symptomtext
Patient seen in the office 8/1/22 complaining of left arm pain and redness. Stated that she got vaccine on 7/27/22 and had a small circular area around the injection site but then on Saturday the reddened area quickly spread. Patient seen by PCP and given course of antibiotics.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma, CAD, DM, hyperlipidemia, HTN, hypothyroid, Murmur
- Andere Medikamente
- Aspirin, Glimepiride, hctz, irbesartan, metformin, synthroid
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 31.07.2022
- Impfdatum
- 22.07.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Blood pressure decreased
Cold sweat
Dizziness
Vaccination site swelling
Symptomtext
Post vaccin the injection site swelled up. Asked the patient to stay seated and relax. Checked back in 5 minutes patient said she felt light headed and clamy. Checked patient's blood pressure which was lower than normal
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- Blood pressure slightly lower than normal which went back up after a while
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Cholesterol
- Andere Medikamente
- Fenofibrate, Finasteride, fluoxetine, Doxycycline, Minoxidil, Latanprost
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 30.07.2022
- Impfdatum
- 27.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain
Dizziness
Nausea
Vomiting
Symptomtext
Systemic: Abdominal Pain-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: vomit x1
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 25.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 4,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Head discomfort
Headache
Muscular weakness
Pain
Pain in extremity
Symptomtext
Patient stated on 7/26 in the evening her arm started to become sore and then over the next several day up today (7/29) she has become achy, feeling pressure in her head and headache, lightheaded, dizzy when she moves too fast and legs feel weak. She reports her bp is normal and has no fever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Nausea
Productive cough
Symptomtext
patient had clear mucus production which caused heavy coughing. She also felt a bit nauseous. She didn't have any other symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 25.07.2022
- Beginn
- 25.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash erythematous
Symptomtext
Patient has large red circular rash on side of the arm that received vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 28.07.2022
- Impfdatum
- 25.07.2022
- Beginn
- 25.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Rash
Rash pruritic
Symptomtext
Patient describes her arm after shot to be very sore and also patient had a red large rash on the side of her arm that is very itchy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anxiety
Dizziness
Flushing
Haemorrhage
Hyperhidrosis
Injection site bruising
Injection site swelling
Pallor
Swelling
Symptomtext
Site: Bruising at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Severe, Additional Details: I accidentally hit a vein and blood squired out, applied pressure to stop bleeding and applied cold pack to reduce swelling, pt felt very faint, profusely sweating, pale in color, pt has high anxiety when getting a shot, talked to pt and kept him alert, supported him so he wouldn't fall and called ambulance asap and by time ambulance arrived, pt had started to stop sweating, color returned to his face and he was feeling better but they still checked all his vital signs and all were good
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 27.07.2022
- Impfdatum
- 26.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Pain in extremity
Symptomtext
Patient had a sore arm after receiving the booster dose. It was administered too closely to the previous dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 23.07.2022
- Beginn
- 24.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
Left upper arm extremely red, swollen and hot. About 7 inches long and 5 inches wide. Urgent care visit. Prescribed topical cream for red swollen rash.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Pre-diabetes, high blood pressure
- Andere Medikamente
- Synthroid, Metformin, Vitamin B12, Fish Oil, Propranolol, Omeprazole, Amlodipine
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 26.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Pain in extremity
Symptomtext
Patient had a sore arm after the administration. This was a dose given outside of recommendations due to an error reporting on the patients behalf.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 16.07.2022
- Beginn
- 16.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Urticaria
Symptomtext
THE PATIENT EXPERIENCED HIVES 4-5 HOURS AFTER HAVING THE SHOT. THE HIVES LASTED FOR 4 DAYS. THE PATIENT WAS TREATED WITH BENADRYL.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Acid Reflux, Thyroid disorder, High Cholesterol , ADHD
- Andere Medikamente
- -
- Allergien
- No Known allergies
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 27.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 23.07.2022
- Tage bis Beginn
- 10,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Peripheral swelling
Pruritus
Pyrexia
Urticaria
Symptomtext
- Hives, contact hives from scratching itchy areas. - Swelling/inflammation of hands and feet - Joint Paint - Persistent low grade fever. - Potential Esophageal Inflammation or Acid reflux (Unsure) Symptoms currently persisting and gradually worsening over three days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Dry skin since second vaccine. Unclear if related to vaccination.
- Andere Medikamente
- None.
- Allergien
- None.
- Vorherige Impfungen
- Itchy rash on torso two months after second dose of Moderna Vaccine. Rash resolved itself on its own after not responding to ant
- Staat
- NE
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 24.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Headache
Injection site swelling
Sinus disorder
Symptomtext
On 7/21/22, after the patient received the Moderna booster, the injection site started to swell. It was a golf ball size. When she stopped by the pharmacy on 7/23/22, the injection site was bigger than a palm size. Patient also has pressure headache and some sinus symptoms. She was using ice packs and antihistamine. She was advice to continue doing those and follow up with the doctor on Monday. I called and checked on the patient on 7/24/22, the injection site swelling didn't get bigger, and her sinus symptoms were also improved. Still advice patient to continue doing ice packs and antihistamine and call her doctor on Monday.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
The patient showed me her arm today, it was red and puffy near where the injection site happened, she was prescribed an antibiotic (keflex) after being seen by the doctor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none known.
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- diabetes
- Andere Medikamente
- metformin, lisinopril, jardiance, praluent, trulicity,
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 20.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Influenza like illness
Myalgia
Nausea
Symptomtext
PATIENT REPORTED STRONG FLU LIKE SYMTOPS THAT STARTED THE DAY AFTER VACCINATIONS MAINLY COMPLAINING ABOUT PAIN IN MUSCLE AND JOINTS AND NAUSEA.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 16.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Lymph node pain
Lymphadenopathy
Symptomtext
Swollen right supraclavicular lymph node(s); Soreness and sensitivity above right clavicle and right side of lower neck region.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lymph node pain
- Hospital-Tage
- -
- Labordaten
- No follow up tests to date. Was instructed by administering pharmacy personnel to monitor for changes.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Fluticasone spray, Diclofenac Sod tablet, Omeprazole capsule, Trintellix tablet, Vyvanse capsule, Amlodipine tablet, Rosuvastatin tablet, Cetirizine tablet & Men's Multivitamin tablet
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
Patient has redness and swelling in the right arm only, near injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- high blood pressure, high cholesterol, mood disorder, thyroid, seasonal allergies, insomnia, anxiety
- Andere Medikamente
- Trazodone 150mg, sertraline 100mg, albuterol HFA, prazosin 2mg, fluticasone nasal spray, buspirone 10mg, cetirizine 10mg, ketotifen eye drops, diltiazem 30mg, advair 250/50 inhaler, pravastatin 20mg, omeprazole 20mg, levothyroxine 150mcg
- Allergien
- NSAIDS, mushrooms
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 14.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Musculoskeletal stiffness
Symptomtext
Patient started having headache and stiffness on the right side for the body
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no other illness
- Vorgeschichte
- Cholesterol,BP
- Andere Medikamente
- Patient is taking tylenol.
- Allergien
- keflex and latex allergies
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
Redness and swelling overlying the injection area
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Papillary thyroid carcinoma, vitamin b12 deficiency
- Andere Medikamente
- Citalopram 20 mg, levothyroxine 125mcg, albuterol inhaler
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 11.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- HTN, HIGH CHOLESTEROL, PAIN, INSOMNIA, ALLERGIES, ASTHMA, DIABETES, RENAL
- Andere Medikamente
- RANOLAZINE ER 500MG, ROSUVASTATIN, MELOXICAM,ZOLPIDEM CARVEDILOL, LISINOPRIL, MONTELUKAST, ZETIA, LEVOTHYROXIN, FLONASE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 22.08.2021
- Impfdatum
- 19.02.2021
- Beginn
- 19.03.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Myalgia
Symptomtext
Joint and muscle pain in his right arm, shoulder, hand, and neck; Joint and muscle pain in his right arm, shoulder, hand, and neck; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint and muscle pain in his right arm, shoulder, hand, and neck) and MYALGIA (Joint and muscle pain in his right arm, shoulder, hand, and neck) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 006M21A) for COVID-19 vaccination. Concurrent medical conditions included COPD and Post-traumatic stress disorder. Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), OXYBUTYNIN, BUDESONIDE, SALBUTAMOL (ALBUTEROL HFA), ATORVASTATIN, VITAMIN B12 NOS, VITAMIN D3, OMEPRAZOLE, METFORMIN, FISH OIL (OMEGA-3 FISH OIL), TRAMADOL, FLUOXETINE, BUSPIRONE, SERTRALINE, BUPROPION, PREGABALIN (LYRICA), ZIPRASIDONE, MAGNESIUM OXIDE and FERROUS SULFATE (IRON SULFATE) for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced ARTHRALGIA (Joint and muscle pain in his right arm, shoulder, hand, and neck) and MYALGIA (Joint and muscle pain in his right arm, shoulder, hand, and neck). At the time of the report, ARTHRALGIA (Joint and muscle pain in his right arm, shoulder, hand, and neck) and MYALGIA (Joint and muscle pain in his right arm, shoulder, hand, and neck) had not resolved. Not Provided Patient took Tylenol as treatment drug. This case was linked to MOD-2021-089115 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- COPD; Post-traumatic stress disorder
- Vorgeschichte
- -
- Andere Medikamente
- CLARITIN ALLERGIC; FLONASE ALLERGY RELIEF; OXYBUTYNIN; BUDESONIDE; ALBUTEROL HFA; ATORVASTATIN; VITAMIN B12 NOS; VITAMIN D3; OMEPRAZOLE; METFORMIN; OMEGA-3 FISH OIL; TRAMADOL; FLUOXETINE; BUSPIRONE; SERTRALINE; BUPROPION; LYRICA; ZIPRASIDON
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 22.08.2021
- Impfdatum
- 13.02.2021
- Beginn
- 13.03.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Antibody test
Night sweats
Pain in extremity
Pyrexia
Symptomtext
Pain in arm; Night sweats worse at night; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), NIGHT SWEATS (Night sweats worse at night) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 006M21A) for COVID-19 vaccination. Concomitant products included LEVOTHYROXINE, LISINOPRIL and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm), NIGHT SWEATS (Night sweats worse at night) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Pain in arm), NIGHT SWEATS (Night sweats worse at night) and PYREXIA (Fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2021-086114, US-MODERNATX, INC.-MOD-2021-085994, US-MODERNATX, INC.-MOD-2021-086095 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-086114:Case for dose 1 US-MODERNATX, INC.-MOD-2021-085994:Case for husband US-MODERNATX, INC.-MOD-2021-086095:Case for husband
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Test Name: Antibody test; Test Result: Negative ; Result Unstructured Data: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- LEVOTHYROXINE; LISINOPRIL; CRESTOR
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 22.08.2021
- Impfdatum
- 13.02.2021
- Beginn
- 13.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Vaccination site pain
Symptomtext
sore arm at injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at injection site) and FATIGUE (Fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M21A and 001B21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LEVOTHYROXINE, LISINOPRIL and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm at injection site) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE PAIN (sore arm at injection site) and FATIGUE (Fatigue) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment drugs were reported. She is concerned about why she doesn't have antibodies to the vaccine and wants answers. This case was linked to US-MODERNATX, INC.-MOD-2021-086192 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-086192:Case for dose 2
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: No medical history was provided by the reporter.
- Andere Medikamente
- LEVOTHYROXINE; LISINOPRIL; CRESTOR
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 22.08.2021
- Impfdatum
- 13.02.2021
- Beginn
- 12.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ageusia
Fatigue
Pain in extremity
Symptomtext
Loss of taste; Sore arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), AGEUSIA (Loss of taste) and FATIGUE (Fatigue) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included WARFARIN, METOPROLOL, OXYBUTYNIN and LEVOTHYROXINE for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced FATIGUE (Fatigue). On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 16-Feb-2021, the patient experienced AGEUSIA (Loss of taste). At the time of the report, PAIN IN EXTREMITY (Sore arm), AGEUSIA (Loss of taste) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: No medical history was provided by the reporter.
- Andere Medikamente
- WARFARIN; METOPROLOL; OXYBUTYNIN; LEVOTHYROXINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 18.12.2023
- Impfdatum
- 11.04.2023
- Beginn
- 13.12.2023
- Tage bis Beginn
- 246,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
SARS-CoV-2 test
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- IDNOW
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, DM type 2, hypothyroidism, hyperlipidemia
- Andere Medikamente
- -
- Allergien
- Aspirin, metformin
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 25.10.2023
- Impfdatum
- 29.07.2022
- Beginn
- 09.12.2022
- Tage bis Beginn
- 133,0
- Dosis
- 1
- Route/Site
- SC / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Biopsy artery abnormal
Giant cell arteritis
Symptomtext
Bilateral severe Temporal arteritis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Biopsy artery abnormal
- Hospital-Tage
- -
- Labordaten
- Severe Giant Cell Arteritis, right temporal artery biopsy 2/8/2023
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- Albuterol inhaler prn Sumetriptan prn
- Allergien
- grass
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 05.09.2023
- Impfdatum
- 31.08.2022
- Beginn
- 02.09.2023
- Tage bis Beginn
- 367,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Symptomtext
found down on the floor by family memberCOVID-19 results are positive, will start dexamethasone and order CRP levels to determine need for IL-6 inhibitors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, HLD, suspected R lung malignancy s/p RUL resection, prostate CA s/p tx
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 14.08.2023
- Impfdatum
- 10.12.2021
- Beginn
- 06.01.2023
- Tage bis Beginn
- 392,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Breakthrough COVID-19
Symptomtext
Covid-19 Breakthrough Infection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Breakthrough COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Dementia, HTN, Bradycardia, CKD, DM type II
- Andere Medikamente
- Lorazepam, Morphine,
- Allergien
- Neosporin
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 14.08.2023
- Impfdatum
- 08.08.2022
- Beginn
- 09.02.2023
- Tage bis Beginn
- 185,0
- Dosis
- 4
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Breakthrough COVID-19
Symptomtext
Breakthrough Covid-19 Infection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Breakthrough COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Chronic AFIB, DM type II, GERD, HTN, Hyperthyroidism, DDD, Scoliosis, Glaucoma, Constipation, Anxiety, Depression, HX. Breast Cancer, DVT
- Andere Medikamente
- Amiodarone, Calcium+ Vit. D, Colchicine, Coumadin, Diltiazem, Furosemide, Insulin Lispro, Levothyroxine, Mag-Ox, Melatonin, MiraLAX, Morphine, Multivitamin, Myrbetriq, Nitroglycerin, Pantoprazole, Potassium. Prozac, Senna, Solifenacin, Zofr
- Allergien
- Tylox, Demerol, Albuterol, Codeine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 26.07.2023
- Impfdatum
- 13.07.2022
- Beginn
- 07.06.2023
- Tage bis Beginn
- 329,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Blood pressure decreased
Mental status changes
Symptomtext
6/7/2023 - 6/11/2023 (4 days) Presented to the hospital with altered mental status and diminished blood pressure. 012M20A 1/28/2021 002A21A 3/1/2021 939909 11/13/2021 006M21A 7/13/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood pressure decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 22.06.2023
- Impfdatum
- 25.07.2022
- Beginn
- 15.03.2023
- Tage bis Beginn
- 233,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Moderna 4/7/21 lot# 017B21A; Moderna 9/16/21 lot# 053C21A; Moderna 11/10/21 lot# 062E21A; Moderna 7/25/22 lot# 006M21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID+
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 01.08.2022
- Beginn
- 27.04.2023
- Tage bis Beginn
- 269,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
COVID vaccine breakthrough case. Moderna 1/23/21 012L20A, 2/16/21 004M20A, 11/14/21 034F21A, and 8/1/22 006M21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Positive COVID test 4/27/23
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 10.04.2023
- Impfdatum
- 13.02.2021
- Beginn
- 27.03.2023
- Tage bis Beginn
- 772,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 20.03.2023
- Impfdatum
- 20.03.2023
- Beginn
- 20.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient was given a Moderna Booster on 8/10/22- Patient was 12y 5m. Provider noticed on 12/30/22 when she completed it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 10.03.2023
- Impfdatum
- 03.08.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 83,0
- Dosis
- 3
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Exposure during pregnancy
Symptomtext
At the time of receiving this vaccine, I was 26 weeks and 2 days pregnant. My son was born on October 25, 2022 (at 38w1d) weighing 7 pounds 8 ounces. His circumcision was performed on his second day of life and the site would not stop bleeding. After multiple unsuccessful applications of surgicel gauze, a pediatric urologist gave him three stitches. His penis bruising turned black over the subsequent two weeks. Additionally, on day three of life, his bilirubin was tested and came back at 19.9 mg/dL. He spent three days in a bilirubin light therapy box. During that time we did daily heel pricks to reevaluate his bili levels. Results were 20.1 on day two and 13.1 mg/dL on day three. There was significant bruising associated with the daily heel pricks. At two weeks old (11-8-22), his umbilical cord fell out and his belly button began to bleed. We then had a CBC done and found his platelets count was 9,000/uL. We were admitted to Hospital for 2 days. Dr (hematologist) diagnosed child with autoimmune thrombocytopenia and administered an IVIG as well as a platelet transfusion. After the transfusions his platelets were up to 49,000 and we were discharged from the hospital. At six weeks old (12-6-22), we had a follow up blood draw and child's platelets were at 50,000/uL. At seven weeks old (12-13-22), we were readmited to Hospital with platelet count down to 18,000 and bilirubin back up to 10. We were observed for two days and released with an expectation to continue follow ups with Dr. At eight weeks old (12-20-22), Dr ran another blood work and child's platelets were up to 211,000. At 12 weeks old (1-19-23), Dr ran another blood work and child's platelets were at 138,000 K/mm3 (L). At that time Dr determined child's platelets were stable and we no longer needed additional monitoring.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- 4,0
- Labordaten
- 10/28/2022: TOTAL BILIRUBIN 19.9 mg/dL 10/29/2022: TOTAL BILIRUBIN 20.5 mg/dL 11/1/2022: TOTAL BILIRUBIN 13.1 mg/dL 11/7/2022: PLATELET COUNT 9 K/uL 11/22/2022: PLATELET COUNT 26 K/mm3 12/6/2022: PLATELET COUNT 50 K/mm3 12/14/2022: TOTAL BILIRUBIN 7.3 mg/dL 12/20/2022: PLATELET COUNT 211 K/mm3 1/19/2023: PLATELET COUNT 138 K/mm3
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Spondylolisthesis
- Andere Medikamente
- Prenatal Vitamins, Iron Supplement, Vitamin D Supplement, Magnesium Supplement, Folic Acid Supplement
- Allergien
- Tramadol
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 03.03.2023
- Impfdatum
- 20.07.2022
- Beginn
- 07.08.2022
- Tage bis Beginn
- 18,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tumour marker test
Vaginal haemorrhage
Symptomtext
Gross vaginal bleeding starting on 08/07/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tumour marker test
- Hospital-Tage
- -
- Labordaten
- CA 125 tumor marker lab test with negative results
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hx CVA, hemiplegia and hemiparesis, vascular dementia, , anemia, hx, breast cancer with mastectomy, COPD, anemia, essential hypertension, dysphagia, Atherosclerotic heart disease of native coronary artery without angina pectoris, Peripheral vascular disease, GERD< dementia,
- Andere Medikamente
- Simethicone, Potassium chloride, Culturelle, Prilosec, Lipitor, Linzess
- Allergien
- Ativan
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 21.02.2023
- Impfdatum
- 27.07.2022
- Beginn
- 04.01.2023
- Tage bis Beginn
- 161,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Moderna 2/4/21 Lot# 013M20A; Moderna 3/4/21 Lot# 030A21A; Moderna 11/23/21 Lot# 012H21B; Moderna 7/27/22 Lot# 006M21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 09.02.2023
- Impfdatum
- 29.07.2022
- Beginn
- 15.01.2023
- Tage bis Beginn
- 170,0
- Dosis
- 4
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Cough
SARS-CoV-2 test negative
Symptomtext
I received my Covid-19 vaccine on 07/29/2022. On 01/15/2023 I started to have a bad cough. I reached out to urgent care and was tested negative for Covid-19. I was prescribed Amoxicillin for 5-10 days .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- Covid-19 test Negative
- Aktuelle Erkrankungen
- Urine infections
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- Moderna vaccine dose 3, 11/04/2021, age 81, didnt feel good after a day
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 28.01.2023
- Impfdatum
- 15.07.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 7,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anal cancer
Herpes zoster
Papilloma viral infection
Perineal cyst
Symptomtext
After the second booster, 4th vaccine the first week brought on shingles on both sides of lower back. Second week started with perineal lump that after few months turned into anal cancer from HPV. Seems like this vaccine wiped out immune system.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anal cancer
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypothyroid, high cholesterol, glaucoma
- Andere Medikamente
- Levothyroxine, rosuvastatin, latanaprost eye drops
- Allergien
- Ampicillin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 26.01.2023
- Impfdatum
- 20.01.2023
- Beginn
- 20.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
Provided expired vaccine, no adverse affects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 19.01.2023
- Impfdatum
- 21.07.2022
- Beginn
- 18.01.2023
- Tage bis Beginn
- 181,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
COVID vaccine breakthrough case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID positive test 1/18/23
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 16.07.2022
- Beginn
- 02.01.2023
- Tage bis Beginn
- 170,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cough
Haemorrhage
Sinus congestion
Sinusitis
Symptomtext
I had a cough, sinus congestion with blood, I did not have a fever that turned out to be a sinus infection. I called and had a telehealth visit with doctor who advised me to use a saline rinse and also prescribed Augmentin. I am now feeling much better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- Zyrtec; Flonase
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 21.12.2022
- Impfdatum
- 10.08.2022
- Beginn
- 18.12.2022
- Tage bis Beginn
- 130,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Moderna 2/11/21 Lot# 007M20A; Moderna 3/11/21 Lot# 023M20A; Moderna 12/8/21 Lot# 005C21A; Moderna 8/10/22 Lot# 006M21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; expired dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose) and NO ADVERSE EVENT (No adverse event) in a 32-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (expired dose). No concomitant medications was reported. Vial size was 5.5ml the vial was initially stored in the refrigerator on 21Oct2022 the vial did not undergo any temperature excursions. It was reported that dose was administered after the published expiration date. The patient did not reported symptoms. Patient did not taken additional doses, medications, or treatments. No treatment medications was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 08.11.2022
- Impfdatum
- 15.07.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 103,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Symptomtext
Admitted to hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 04.11.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No Adverse event; Received expired 2nd primary dose, 1.5 months after manufacturer expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired 2nd primary dose, 1.5 months after manufacturer expiration date) and NO ADVERSE EVENT (No Adverse event) in a 73-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Nov-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 01-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired 2nd primary dose, 1.5 months after manufacturer expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired 2nd primary dose, 1.5 months after manufacturer expiration date) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Received expired 2nd primary dose, 1.5 months after manufacturer expiration date). No concomitant medications were provided. Caller did not had information on first dose of patient. No treatment medication was provided. Reporter did not allow further contact
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 03.11.2022
- Impfdatum
- 16.02.2021
- Beginn
- 07.09.2022
- Tage bis Beginn
- 568,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Colostomy
SARS-CoV-2 test positive
Symptomtext
09/07/22 presents to General Surgery for "colostomy". PMHx of "cardiac history, including severe AS who has chronic proctitis s/p radiation and fecal incontinence"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 09/07/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 01.11.2022
- Impfdatum
- 16.07.2022
- Beginn
- 24.07.2022
- Tage bis Beginn
- 8,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anti-thyroid antibody positive
Blood test abnormal
Blood thyroid stimulating hormone normal
Hypothyroidism
Immunisation reaction
Symptomtext
Nine days after receiving my fourth dose of Moderna, I had routine blood work done and for the first time in my life, my thyroid levels were low. My doctor did indicate that he thought there could be some relation to my recent vaccine. I did not have any symptoms, which I conveyed to the doctor. He stated it could be subclinical hypothyroidism but would need further checking to properly diagnose. After three months, I had more blood work done and a TPO. My levels were high on the TPO, but my THS numbers had gone back to normal. So, at this time, there is no need for further treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anti-thyroid antibody positive
- Hospital-Tage
- -
- Labordaten
- 24JUL2022-Blood Work- Slightly Elevated THS Levels; 27OCT2022- Blood Work- Normal THS Levels; TPO- High Levels Indicated
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Biotin; Vitamin D; Magnesium
- Allergien
- Penicillin; Sulfa
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 26.09.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product expiration date issue
Symptomtext
Expiration date doesn't match expiration date given under moderna lot number look up on the moderna website.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product expiration date issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 26.09.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product expiration date issue
Symptomtext
Expiration date doesn't match expiration date given under Moderna lot number look u on the website.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product expiration date issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.10.2022
- Impfdatum
- 06.10.2022
- Beginn
- 06.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial stored in the refrigerator after 30 day use by date; No adverse event; 1 dose of an expired vaccine administered to one patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1 dose of an expired vaccine administered to one patient), PRODUCT STORAGE ERROR (The vial stored in the refrigerator after 30 day use by date) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 06-Oct-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 06-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (1 dose of an expired vaccine administered to one patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial stored in the refrigerator after 30 day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (1 dose of an expired vaccine administered to one patient), PRODUCT STORAGE ERROR (The vial stored in the refrigerator after 30 day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (1 dose of an expired vaccine administered to one patient) and PRODUCT STORAGE ERROR (The vial stored in the refrigerator after 30 day use by date). The vial size was unknown. The vial was initially stored in the refrigerator on 03-Aug-2022. The vial does not undergone any temperature excursions. No concomitant medications was reported. No treatment medications was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 22.10.2022
- Impfdatum
- 17.09.2022
- Beginn
- 17.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired Moderna vaccine given; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccine given) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Sep-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 17-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccine given). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccine given) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccine given). No concomitant medications were provided. The nurse practitioner stated that expired Moderna vaccine was given. The dose on the vial was 100 mcg/0.5 ml, but the vial volume was unknown. The patient information was unknown, but it was the second dose for the patient. The nurse practitioner did not have the date of initial thaw. The date of vial which was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. No treatment medication was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.10.2022
- Impfdatum
- 26.09.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Wrong product administered
Symptomtext
No adverse event; Received Expired Monovalent Booster of Moderna COVID-19 vaccine; Received Monovalent Booster instead of Bivalent; This spontaneous case was reported by a phlebotomist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent Booster of Moderna COVID-19 vaccine), WRONG PRODUCT ADMINISTERED (Received Monovalent Booster instead of Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent Booster of Moderna COVID-19 vaccine) and WRONG PRODUCT ADMINISTERED (Received Monovalent Booster instead of Bivalent). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent Booster of Moderna COVID-19 vaccine), WRONG PRODUCT ADMINISTERED (Received Monovalent Booster instead of Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent Booster of Moderna COVID-19 vaccine) and WRONG PRODUCT ADMINISTERED (Received Monovalent Booster instead of Bivalent). No concomitant medications were reported. No treatment medications were reported. This case contains information for the 2nd of 2 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-661313 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-661313:1st adult patient case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.10.2022
- Impfdatum
- 26.09.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Wrong product administered
Symptomtext
No adverse event; Received Expired Monovalent Booster; Received Monovalent Booster instead of Bivalent; This spontaneous case was reported by a phlebotomist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent Booster), WRONG PRODUCT ADMINISTERED (Received Monovalent Booster instead of Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent Booster) and WRONG PRODUCT ADMINISTERED (Received Monovalent Booster instead of Bivalent). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent Booster), WRONG PRODUCT ADMINISTERED (Received Monovalent Booster instead of Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received Expired Monovalent Booster) and WRONG PRODUCT ADMINISTERED (Received Monovalent Booster instead of Bivalent). No Concomitant medications were provided. No treatment medications were provided. This case contains information for the 1st of 2 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-661317 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-661317:2nd adult patient case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 21.10.2022
- Impfdatum
- 26.09.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No Adverse Event; Received an expired Moderna COVID19 booster; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received an expired Moderna COVID19 booster) and NO ADVERSE EVENT (No Adverse Event) in a 78-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 006m21a) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 26-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received an expired Moderna COVID19 booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received an expired Moderna COVID19 booster) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. Concomitant product use was not provided by the reporter. It was reported that patient received an expired Moderna COVID19 booster. Caller stated the vaccine expired on 16 Sep 2022, Vial expiration checker showed that the expiration date was 15 Sep 2022. Treatment information was not provided. This case was linked to MOD-2022-660008 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 18.10.2022
- Impfdatum
- 12.10.2022
- Beginn
- 12.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Expired on 15SEP2022, initially stored in the refrigerator on 12OCT2022, administration of vaccine on 12OCT2022; no adverse events; patient received an expired Monovalent First Primary (Presumed repeat) dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received an expired Monovalent First Primary (Presumed repeat) dose), PRODUCT STORAGE ERROR (Expired on 15SEP2022, initially stored in the refrigerator on 12OCT2022, administration of vaccine on 12OCT2022) and NO ADVERSE EVENT (no adverse events) in a 26-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (Dose 1, Unknown Brand and On unknown date in another country). Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine. On 12-Oct-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received an expired Monovalent First Primary (Presumed repeat) dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired on 15SEP2022, initially stored in the refrigerator on 12OCT2022, administration of vaccine on 12OCT2022) and NO ADVERSE EVENT (no adverse events). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received an expired Monovalent First Primary (Presumed repeat) dose), PRODUCT STORAGE ERROR (Expired on 15SEP2022, initially stored in the refrigerator on 12OCT2022, administration of vaccine on 12OCT2022) and NO ADVERSE EVENT (no adverse events) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse events) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient received an expired Monovalent First Primary (Presumed repeat) dose) and PRODUCT STORAGE ERROR (Expired on 15SEP2022, initially stored in the refrigerator on 12OCT2022, administration of vaccine on 12OCT2022). Concomitant medications were not reported. They were not sure of spacing between first and second primary shot. The vial size was 5.5 ml. The vial did not undergo any temperature excursions Treatment medications were not reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 16.10.2022
- Impfdatum
- 16.10.2022
- Beginn
- 16.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 16.10.2022
- Impfdatum
- 16.10.2022
- Beginn
- 16.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- None reported
- Allergien
- Sulfa drugs
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 15.10.2022
- Impfdatum
- 12.10.2022
- Beginn
- 12.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Adult patient received expired Moderna Covid-19 vaccine for the second series of his primary series of the Moderna Covid-19 vaccine.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Moderna Covid-19 vaccine for the second series of his primary series of the Moderna Covid-19 vaccine.) and NO ADVERSE EVENT (No adverse event) in a 32-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Oct-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Moderna Covid-19 vaccine for the second series of his primary series of the Moderna Covid-19 vaccine.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Moderna Covid-19 vaccine for the second series of his primary series of the Moderna Covid-19 vaccine.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Moderna Covid-19 vaccine for the second series of his primary series of the Moderna Covid-19 vaccine.). No concomitant medications were reported. The patient received his first primary series dose of the Moderna COVID-19 vaccine on 07-Sep-2022 lot number 082B22A expiration date was 22-Nov-2022 in the left arm. No adverse reactions experienced. Vial size was 5.5ml. Vial was initially stored in the refrigerator on 12-Oct-2022. The vial did not undergo any temperature excursions. No treatment drugs were reported. Most recent FOLLOW-UP information incorporated above includes: On 13-Oct-2022: Follow-up received wherein patient demographics and suspect product indication updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 14.10.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
The lot number used for this vaccination (006M21A) expired on 9.15.22, however, the dose was given on 9.28.22. No adverse reaction occurred, logging due to expired vaccine given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 12.10.2022
- Impfdatum
- 12.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Expired Vaccine was administered. Expiration Date 09/15/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- Anxiety Hyperlipidemia
- Andere Medikamente
- Alprazolam Fenofibrate
- Allergien
- Pollen
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
I am in a satellite clinic of the local Memorial group and receive the Covid vaccinations every other Wednesday from the local clinic for that day's vaccination clinic. On this day I had 1 pt scheduled for a first time Covid vaccine and received 1 bottle of monovalent Moderna. This patient came in requesting vaccination. We discussed we didn't have the multivalent vaccine and shared the information we received from the local clinic that we didn't know when we would receive it. The pt decided to receive the booster dose of monovalent Moderna and then wait for the multivalent dose when it was available. After the dose was administered we were made aware that the multivalent dose was available but not sent to us.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Osteoarthritis
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
I am in a satellite clinic of the local Memorial group and receive the Covid vaccinations every other Wednesday from the local clinic for that day's vaccination clinic. On this day I had 1 pt scheduled for a first time Covid vaccine and received 1 bottle of monovalent Moderna. This patient came in requesting vaccination. We discussed we didn't have the multivalent vaccine and shared the information we received from the local clinic that we didn't know when we would receive it. The pt decided to receive the booster dose of monovalent Moderna and then wait for the multivalent dose when it was available. After the dose was administered we were made aware that the multivalent dose was available but not sent to us.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Osteoarthritis
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 07.10.2022
- Impfdatum
- 28.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
I run a satellite clinic currently and receive necessary doses of vaccines from the main Clinic. I was sent 1 bottle of monovalent Moderna vaccine. I had 1 pt on the schedule for an initial vaccination. This patient and his wife came in desiring boosters of Covid vaccine. He reports receiving 2 doses of Pfizer last year. I explained we didn't have the multivalent dose as I was told it was not available yet, and received just the monovalent vaccine. The patient and his wife both elected to receive this vaccine and would wait for the multivalent vaccine when it was available. I was asked by the clinic to submit this variance report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- RA Hyperlipidemia Osteoarthritis
- Andere Medikamente
- Methotrexate Statin Celebrex
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 07.10.2022
- Impfdatum
- 28.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
I run a satellite clinic currently and receive necessary doses of vaccines from the main Clinic. I was sent 1 bottle of monovalent Moderna vaccine. I had 1 pt on the schedule for an initial vaccination. This patient and his wife came in desiring boosters of Covid vaccine. He reports receiving 2 doses of Pfizer last year. I explained we didn't have the multivalent dose as I was told it was not available yet, and received just the monovalent vaccine. The patient and his wife both elected to receive this vaccine and would wait for the multivalent vaccine when it was available. I was asked by the clinic to submit this variance report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- RA Hyperlipidemia Osteoarthritis
- Andere Medikamente
- Methotrexate Statin Celebrex
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 04.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; patient received an expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received an expired vaccine) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received an expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received an expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient received an expired vaccine). No concomitant medications were reported. HCP reported that a patient received the Monovalent expired vaccine on 04-Oct-2022 and Patient didn't experience any side effects. It was reported that dose was administered 30 days after date of expiry. Vial size was mentioned as 5.5 ml. The vial was stored in the refrigerator on 07-Sep-2022 and The Vial didn't undergo temperature excursion study.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.10.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired dose was administered to a patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose was administered to a patient) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose was administered to a patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose was administered to a patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired dose was administered to a patient). No concomitant medication was reported. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 30.09.2022
- Beginn
- 30.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
PATIENT WAS GIVEN EXPIRED VACCINE. UNKNOWN OF ANY ADVERSE EVENTS AT THIS TIME
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 23.09.2022
- Beginn
- 23.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; expired vaccine administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine administered to patient) and NO ADVERSE EVENT (No adverse event) in a 23-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. Patient doesn't have any allergies (medications, food and other products) and patient never tested COVID-19 positive test or diagnosis. Patient received no other vaccines within one month prior to Moderna COVID-19 vaccine. No history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. On 23-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 23-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (expired vaccine administered to patient). Patients year of birth was reported. No concomitant medication. It was reported vial was in open carton in the freezer and vial size was 5.5 mL and vial had not undergone any temperature excursions. It was also on 23-SEP-2022 around 5pm the dose was administered to patient and adverse event had not caused patient to seek medical care (office visit, Urgent care, ER, hospitalized). It was reported that the reporter had not seen the vaccine expiration warning and later noted the expiry date. 2 primary full doses were administered to 2 patients. Reporter stated that the reporters colleague checked in with the patients to see how they were feeling and they had no complaints. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 26-Sep-2022: Live follow up received: updated reporter state, updated narrative.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: Patient doesn't have any allergies (medications, food and other products) and patient never tested COVID-19 positive test or diagnosis. Patient received no other vaccines within one month prior to Moderna COVID-19 vaccine. No history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 23,0
- Geschlecht
- M
- Eingang
- 30.09.2022
- Impfdatum
- 23.09.2022
- Beginn
- 23.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Vaccine was expired on 15-Sep-2022 and was administered to the patient on 23-Sep-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 15-Sep-2022 and was administered to the patient on 23-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 23-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. Patient had no allergies to medications, food and other products were reported. Concurrent medical conditions included Tuberculosis (Current active infection). Concomitant products included ISONIAZID and RIFAMPIN for an unknown indication. On 23-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 23-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 15-Sep-2022 and was administered to the patient on 23-Sep-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 15-Sep-2022 and was administered to the patient on 23-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 15-Sep-2022 and was administered to the patient on 23-Sep-2022). Patient was not diagnosed or tested positive for COVID-19. Patient had not received other vaccines within 1 month prior to Moderna COVID-19 vaccine. It was reported vial was in open carton in the freezer and vial size was 5.5 mL and vial had not undergone any temperature excursions. It was reported that the vaccine was administered to the patient on 23-Sep-2022 around 5pm. The adverse event had not caused patient to seek medical care (office visit, Urgent care, ER or hospitalized). It was reported that the reporter had not seen the vaccine expiration warning and later noted the expiry date. It was reported that 2 primary full doses were administered to 2 patients. Reporter stated that the reporters colleague checked in with the patients to see how they were feeling and they had no complaints. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 26-Sep-2022: Live significant follow up received contains patient details and I narrative were updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Tuberculosis (Current active infection)
- Vorgeschichte
- Comments: Patient had no allergies to medications, food and other products were reported.
- Andere Medikamente
- ISONIAZID; RIFAMPIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
given 21 doses that it was expired recently, had just taken it out of the freezer; No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event) in a 32-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. It was unknown if patient had any allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. It was known if patient had any chronic or long standing health conditions. On 20-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer). No concomitant medication were reported. Patient received Monovalent vaccine. Individual vials of size 5.5 ml. The vial was initially stored in the refrigerator on 20Sep2022. The vial did not undergo any temperature excursions No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Follow up received: Reporter address updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown if patient had any allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. It was known if patient had any chronic or long standing health conditions.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. It was unknown if patient had allergies to medication, foods and other products. It was unknown if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). No concomitant medications were reported. Expired Moderna vaccine was given to the patient. The vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo temperature excursion. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received, updated reporter details.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown if patient had allergies to medication, foods and other products. It was unknown if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 21-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). No concomitant medications were reported. Anatomical location of administration was reported as left. It was unknown if patient had allergies to medication, foods and other products. It was unknown if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. Expired Moderna vaccine had been given to 21 patients. The reporter explained that the vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergone any temperature excursion. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow-up contains updated reporter details.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
expired vial was initially stored in the refrigerator on 20-Sep-2022; No adverse event; Expired vaccine was administered after the manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry), PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 52-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry), PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry) and PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022). No concomitant medication were reported. It was reported that patient received 0.5 dose of vaccine during PM time. It was unknown that patient had ever been diagnosed with nor tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination up to one month before. It was unknown if patient had any chronic or long standing health conditions. It was reported that HCP gave Moderna Covid 19 vaccines and it was discovered after they had given 21 doses that it was expired recently from monovalent Individual vials of Vial size 5.5 ml. The vial had not undergone any temperature excursions. No treatment medication were reported. This case was linked to US-MODERNATX, INC.-MOD-2022-648572 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Follow up received contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2022-648572:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). It was unknown if patient had any allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. Not known if patient had any chronic or long standing health conditions. No concomitant medication was reported. Patient received Monovalent vaccine. Individual vials of size 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live non-significant follow up received contains: reporter details updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 20-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. It was unknown if patient had allergies to medication, foods and other products. It was unknow if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. On 20-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Expired Moderna vaccine was given to the patient. The vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo temperature excursion. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received, updated reporter details.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown if patient had allergies to medication, foods and other products. It was unknow if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 23,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
given 21 doses that it was expired recently, had just taken it out of the freezer; No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event) in a 23-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. It was unknown whether patient had allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. It was unknown if patient had any chronic or long standing health conditions. On 20-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer). No concomitant medication were reported. Patient received Monovalent vaccine. Individual vials of size 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo any temperature excursions No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received contains reporter address updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown whether patient had allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. It was unknown if patient had any chronic or long standing health conditions.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Expired vial was initially stored in the refrigerator on 20-Sep-2022; No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (Expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 31-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (Expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Expired vial was initially stored in the refrigerator on 20-Sep-2022). Concomitant product use was not provided by the reporter. The information was unknown whether the patient had ever been diagnosed with or tested positive with COVID-19. The information of acute illness at the time of vaccination and up to one month before was unknown. Expired Moderna vaccine was given to the patient. The vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo temperature excursion. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-648572 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow-up information received included updated reporters address.; Sender's Comments: US-MODERNATX, INC.-MOD-2022-648572:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
expired vial was initially stored in the refrigerator on 20-Sep-2022; No adverse event; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine), PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. It was unknown if patient had allergies to medication, foods and other products. It was unknow if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine), PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022). No concomitant medications were reported. Patient received 0.5 dose of vaccine at PM time. Expired Moderna vaccine had been given to 21 patients. The reporter explained that the vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo any temperature excursion. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received with updated reporter's address.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown if patient had allergies to medication, foods and other products. It was unknow if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. It was unknown if patient had any allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. Not known if patient had any chronic or long standing health conditions. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). No concomitant medication were reported. Patient received Monovalent vaccine. Individual vials of size 5.5 ml. The vial was initially stored in the refrigerator on 20Sep2022. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live Non-significant follow up received contains: reporter details updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown if patient had any allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. Not known if patient had any chronic or long standing health conditions.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 52-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. Allergies to medication, food and other products were unknown. It was unknown if the patient had ever been diagnosed or tested positive for COVID-19. Chronic and acute illness at the time of vaccination and one month prior was unknown. On 20-Sep-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). The patient received the vaccine on the left. Concomitant medication list was not provided. It was reported that they gave monovalent Moderna COVID-19 vaccines and it was discovered after they had given 21 doses that was expired recently. Vials were individual vials and vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial had not underwent any temperature excursions. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Follow up received: updated reporter details.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: Allergies to medication, food and other products were unknown. It was unknown if the patient had ever been diagnosed or tested positive for COVID-19. Chronic and acute illness at the time of vaccination and one month prior was unknown.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 28.09.2022
- Impfdatum
- 23.09.2022
- Beginn
- 23.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
The patient didn't have an adverse event. This is a reported administration error. The patient was given an expired vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 41,0
- Geschlecht
- U
- Eingang
- 28.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
given 21 doses that it was expired recently, had just taken it out of the freezer; No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event) in a 41-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and PRODUCT STORAGE ERROR (given 21 doses that it was expired recently, had just taken it out of the freezer). It was unknown if patient had any allergies to medications, food and other products. It was unknown if patient was ever been diagnosed or tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination or a month before vaccination. Not known if patient had any chronic or long standing health conditions No concomitant medication were reported. Patient received Monovalent vaccine. Individual vials of size 5.5 ml. The vial was initially stored in the refrigerator on 20Sep2022. The vial did not undergo any temperature excursions No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received contains reporter address updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 28.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 56-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 004M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. Anatomical location of administration was reported as left. It was unknown if patient had allergies to medication, foods and other products. It was unknow if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. Expired Moderna vaccine had been given to 21 patients. The reporter explained that the vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergone any temperature excursion. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received contains updated reporter details
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 28.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
expired vial was initially stored in the refrigerator on 20-Sep-2022; No adverse event; Expired vaccine was administered after the manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry), PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry), PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry) and PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022). No concomitant medication were reported. It was unknown that patient had ever been diagnosed with nor tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination up to one month before. It was unknown if patient had any chronic or long standing health conditions. It was reported that patient received 0.5 dose of vaccine during PM time. It was reported that HCP gave Moderna Covid 19 vaccines and it was discovered after they had given 21 doses that it was expired recently from monovalent Individual vials of Vial size 5.5 ml. The vial had not undergone any temperature excursions. No treatment medication were reported. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Follow up received contains no new information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- -
- Geschlecht
- M
- Eingang
- 28.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. The information of allergies to medication, food and other products were unknown. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). Concomitant product use was not provided by the reporter. The information was unknown whether the patient had ever been diagnosed with/tested positive with COVID-19. The information of acute illness at the time of vaccination and up to one month before was unknown. Expired Moderna vaccine was given to the patient. The vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo temperature excursion. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-648572 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received with updated reporter's address; Sender's Comments: US-MODERNATX, INC.-MOD-2022-648572:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: The information of allergies to medication, food and other products were unknown.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 28.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
expired vial was initially stored in the refrigerator on 20-Sep-2022; No adverse event; Expired vaccine was administered after the manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry), PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. It was unknown that patient had ever been diagnosed with nor tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination up to one month before. It was unknown if patient had any chronic or long standing health conditions. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry), PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered after the manufacturer date of expiry) and PRODUCT STORAGE ERROR (expired vial was initially stored in the refrigerator on 20-Sep-2022). No concomitant medication were reported. It was reported that patient received 0.5 dose of vaccine during PM time. It was reported that HCP gave Moderna Covid 19 vaccines and it was discovered after they had given 21 doses that it was expired recently from monovalent Individual vials of Vial size 5.5 ml. The vial had not undergone any temperature excursions. No treatment medication were reported. This case was linked to US-MODERNATX, INC.-MOD-2022-648572 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Follow up received contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2022-648572:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown that patient had ever been diagnosed with nor tested positive for COVID-19. It was unknown if patient had any acute illness at the time of vaccination up to one month before. It was unknown if patient had any chronic or long standing health conditions.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 28.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 48-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). No concomitant medications were reported. It was unknown if patient had allergies to medication, foods and other products. It was unknow if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. Expired Moderna vaccine had been given to 21 patients. The reporter explained that the vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergone any temperature excursion. No treatment medications were reported. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received contains reporter address updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 28.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 52-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). No concomitant medications were reported. It was unknown if patient had allergies to medication, foods and other products. It was unknown if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. Expired Moderna vaccine had been given to 21 patients. The reporter explained that the vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergone any temperature excursion. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received contains reporter address updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 28.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 27-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. It was unknown if patient had any allergies. It was unknown if patient ever diagnosed for COVID-19. It was unknown if patient had any acute illness or chronic long lasting condition. On 20-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). No concomitant product reported by reporter. Expired Moderna vaccine had been given to 21 patients. The reporter explained that the vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergone temperature excursion. No treatment medication reported by reporter. Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up information included fax number.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown if patient had any allergies. It was unknown if patient ever diagnosed for COVID-19. It was unknown if patient had any acute illness or chronic long lasting condition.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 23.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Vaccine expiration 9/15/22, vaccine given 9/20/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 23.09.2022
- Impfdatum
- 12.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
No adverse event
Symptomtext
No adverse events reported. Patient was given a booster shot of the Moderna Spikevax 12 years and older. Which is no longer recommended as booster shot as of August 31, 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 23.09.2022
- Impfdatum
- 07.09.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
No adverse events reported. Patient was given a booster shot of the Moderna Spikevax 12 years and older. Which is no longer recommended as booster shot as of August 31, 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 23.09.2022
- Impfdatum
- 07.09.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
No adverse events reported. Patient was given a booster shot of the Moderna Spikevax 12 years and older. Which is no longer recommended as booster shot as of August 31, 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 23.09.2022
- Impfdatum
- 07.09.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No adverse events reported. Patient was given a booster shot of the Moderna Spikevax 12 years and older. Which is no longer recommended as booster shot as of August 31, 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 26,0
- Geschlecht
- U
- Eingang
- 23.09.2022
- Impfdatum
- 19.08.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 32,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022; No adverse event; accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine), PRODUCT STORAGE ERROR (Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch nos. 006M21A and 006M21A) for an unknown indication. The patient had no allergies The patient never tested positive to COVID 19. On 19-Aug-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Sep-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 20-Sep-2022, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine), PRODUCT STORAGE ERROR (Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022). The patient was not taking any concomitant medication. It was reported that Individual vial with 5.5 ml size. The vial did not undergo any temperature excursions. No treatment drug was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: The patient had no allergies The patient never tested positive to COVID 19
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 22.09.2022
- Impfdatum
- 19.09.2022
- Beginn
- 19.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; administered 1 dose of Moderna COVID-19 Vaccine to a patient on 19Sep2022 after expiry date (15Sep2022); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 1 dose of Moderna COVID-19 Vaccine to a patient on 19Sep2022 after expiry date (15Sep2022)) and NO ADVERSE EVENT (No adverse event) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 vaccination. Relevant medical history reported as No Allergies (medications, food and other products). It was unknown if patient ever had COVID positive test or diagnosis. It was unknown if patient had Acute and Chronic illnesses at the time of vaccination. No Other vaccines given within 1 month prior to Moderna COVID-19 vaccine. On 19-Sep-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 1 dose of Moderna COVID-19 Vaccine to a patient on 19Sep2022 after expiry date (15Sep2022)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 1 dose of Moderna COVID-19 Vaccine to a patient on 19Sep2022 after expiry date (15Sep2022)) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered 1 dose of Moderna COVID-19 Vaccine to a patient on 19Sep2022 after expiry date (15Sep2022)). Reporter did not know if patient was under any concomitant or regular medication. Patient received unknown 1st dose of vaccine with unknown Lot number and Expiration date. No AEs were reported. It was unknown when the vaccine vial was initially stored in the refrigerator. The Vial did not undergo any temperature excursion. Reporter did not know if any treatment was given
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: Relevant medical history reported as No Allergies (medications, food and other products). It was unknown if patient ever had COVID positive test or diagnosis. It was unknown if patient had Acute and Chronic illnesses at the time of vaccination. No Other vaccines given within 1 month prior to Moderna COVID-19 vaccine.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 21.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
ON 09/21/22 THE PATIENT RECEIVED MODERNA 2ND BOOSTER WHICH HAD EXPIRED ON 09/15/22. PT WAS OBSERVED FOR 30 MINUTES POST VACCINATION, NO ADVERSE REACTION NOTICED AT TIME , PT WAS TOLD TO GO TO THE EMERENCY ROOM IF ANY ADVERSE EVENT. PT VERBABLIZED THAT SHE DID NOT FEEL ANY SYMPTOMS OF ADVERSITY. CONTACTED MODERNA TO REPORT THE EVENT. AWAITING REPORT FOR LOT NUMBER ANALYSIS FROM MODERNA .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- H/O SEIZURES
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 21.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Used Vial of vaccine that expired on 9/15/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 20.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
No adverse event
Symptomtext
Patient received Moderna Monovalent after the FDA announced a pause in boosting with the Original Monovalent Vaccine and wait until the Covid Bivalent booster dose was available. When the error was discovered, the patient was contacted by phone on 9/7/2022 at 11:30AM to explain the error and that she should return in 2 months to receive the Covid Bivalent booster dose by Public Health Director. No adverse reactions where reported by the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Non known
- Vorgeschichte
- Non known
- Andere Medikamente
- Non known
- Allergien
- Non known
- Vorherige Impfungen
- -
- Staat
- AK
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 20.09.2022
- Impfdatum
- 02.09.2022
- Beginn
- 02.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
This patient was given a booster dose of 0.25 mL out of the original Moderna vial that was no longer under the Emergency Use Authorization. I hadn't read my e-mail received the day before that it was discontinued and to wait until the bivalent vaccines arrived so I helped a co-worker administer this vaccine. I attempted to call this patient on 9/2/2022 to let them know that they are eligible for a bivalent Booster dose in two months but the patient did not answer and I was unable to leave a voicemail. I e-mailed all of the Primary Care and EMS workers at facility to let them know not to give any boosters until the Bivalent booster vials arrive. I e-mailed facility that I had helped a co-worker administer a booster and they let me know that I needed to fill out a VAERS report on 9/8/2022. I haven't had time to do it but I have time today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.09.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired Vaccine Administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Sep-2022 at 9:30 AM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-Sep-2022 at 9:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered). No concomitant medication was reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 19.09.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
PATIENT WAS GIVEN INCORRECT VACCINE FOR HER BOOSTER DOSE. SHOULD HAVE RECIEVED MODERNA BIVALENT FOR BOOSTER, HOWEVER THERE WAS NO MODERNA BIVALENT BOOSTER DOSES IN STOCK AT THE CLINIC. AEMT PROCEEDED TO VACCINATE PATIENT. PATIENT HAS NOT HAD ANY ADVERSE EVENT. SHE IS NOT EXPIERENCING ANY SIDE EFFECTS TO THE VACCINATION.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 17.09.2022
- Impfdatum
- 13.07.2022
- Beginn
- 17.09.2022
- Tage bis Beginn
- 66,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
The patient received a dose of Moderna for her first preliminary dose even though this vaccine is not recommended for her age. No major side effects occurred after receiving the dose so far. The patient's mother will continue to monitor and will report to the child's pediatrician if any adverse reactions occur.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 17.09.2022
- Impfdatum
- 19.08.2022
- Beginn
- 19.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No Adverse event; administration error of the Moderna Covid-19 vaccine on an unauthorized age of a 10-year-old pediatric patient received his 1st dose authorized for the 12 and over age group on 19AUG2022; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration error of the Moderna Covid-19 vaccine on an unauthorized age of a 10-year-old pediatric patient received his 1st dose authorized for the 12 and over age group on 19AUG2022) and NO ADVERSE EVENT (No Adverse event) in a 10-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 19-Aug-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Aug-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration error of the Moderna Covid-19 vaccine on an unauthorized age of a 10-year-old pediatric patient received his 1st dose authorized for the 12 and over age group on 19AUG2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration error of the Moderna Covid-19 vaccine on an unauthorized age of a 10-year-old pediatric patient received his 1st dose authorized for the 12 and over age group on 19AUG2022) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration error of the Moderna Covid-19 vaccine on an unauthorized age of a 10-year-old pediatric patient received his 1st dose authorized for the 12 and over age group on 19AUG2022). Concomitant medications details were not reported by the reporter. Treatment details were not reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 13-Sep-2022: Follow-up document contains updated patient demographics, product indication and dosing details updated accordingly, narrative updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 16.09.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Vaccine was expired when administered on 9/16/22.... Expiration date is 9/15/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- Sulfamethaxazole - trimethoprim
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 15.09.2022
- Impfdatum
- 15.09.2022
- Beginn
- 15.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient given monovalent dose after date of authorization. Authorization expiration date was 8/31/22. Provider unaware of expiration date at the time of administration. Notified of expiration date on 9/14/22, at which time the regulatory authority directed the provider to complete an event report. Shipment of bivalent booster doses was not received until 9/12/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 15.09.2022
- Impfdatum
- 15.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient given monovalent dose after date of authorization. Authorization expiration date was 8/31/22. Provider unaware of expiration date at the time of administration. Notified of expiration date on 9/14/22, at which time the Department of Health directed the provider to complete an event report. Shipment of bivalent booster doses were not received until 9/12/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 19.08.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Symptomtext
No reported adverse events yet.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- Adderall 10 mg
- Allergien
- Boostrix Tdap vaccine
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per healthcare division guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per Regulatory Authority guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per Regulatory Authority guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per Regulatory Authority guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per agency guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per Regulatory Authority guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 12.09.2022
- Impfdatum
- 06.09.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Product administration error
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 11.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 11.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Product administration error
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 11.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per DHA IHD guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 11.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Product administration error
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 11.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per healthcare division guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 11.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 11.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 11.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Per Agency Immunization Healthcare Division guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 10.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- none
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 10.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
no adverse event reported
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 08.09.2022
- Impfdatum
- 06.09.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Moderna vaccine given as booster, should have waited for bivalent Moderna vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 06.09.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
Moderna vaccine given as booster, should have waited for bivalent Moderna vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 06.09.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Moderna vaccine given as booster, when should have waited for bivalent moderna vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 07.09.2022
- Impfdatum
- 31.08.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Per the recommendations of our local health jurisdiction, we are reporting this as an adverse event, since the booster was given after the FDA unauthorized the use of monovalent vaccines as booster doses for individuals 12 years of age and older.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- N/A.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Patient noted she has a weakened immune system caused by something such as HIV infection or cancer and/or she is taking an immunosuppressive drug or therapy.
- Andere Medikamente
- Unknown
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 07.09.2022
- Impfdatum
- 31.08.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Per the recommendations of our local health jurisdiction, we are reporting this as an adverse event as the booster was given after the FDA unauthorized the use of monovalent vaccines as booster doses for individuals 12 years of age and older.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 07.09.2022
- Impfdatum
- 31.08.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Per the recommendations of our local health jurisdiction, we are reporting this as an adverse event as the booster was given after unauthorized the use of monovalent vaccines as booster doses for individuals 12 years of age and older.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 03.09.2022
- Impfdatum
- 02.09.2022
- Beginn
- 02.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Vaccination error
Symptomtext
Gave shot before the bivalent vaccine was approved. Ran at end of day after bivalent approved. No side effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- Macrolides and Penicillin
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 02.09.2022
- Impfdatum
- 17.08.2022
- Beginn
- 17.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
SARS-CoV-2 test
Symptomtext
The vial was initially stored in refrigerator on 14-Jul-2022 and was admininstered on 17-Aug-2022; No adverse event; Patient was administered with a booster dose of the Moderna Covid 19, after its expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with a booster dose of the Moderna Covid 19, after its expiration date.), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 14-Jul-2022 and was admininstered on 17-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (1st dose,Lot#: FEA092681) on 19-Mar-2021, PFIZER BIONTECH COVID-19 VACCINE (2nd Dose,Lot#: ER8734) on 09-Apr-2021, PFIZER BIONTECH COVID-19 VACCINE (1st Booster dose andLot#: FH8028) on 18-Nov-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. On 17-Aug-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with a booster dose of the Moderna Covid 19, after its expiration date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 14-Jul-2022 and was admininstered on 17-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with a booster dose of the Moderna Covid 19, after its expiration date.), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 14-Jul-2022 and was admininstered on 17-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive 2 months ago. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with a booster dose of the Moderna Covid 19, after its expiration date.) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 14-Jul-2022 and was admininstered on 17-Aug-2022). No concomitant medications were reported. The expiration date of vial was 13-Aug-2022. The vial was initially placed in the refrigerator on 14-Jul-2022. The vial did not undergo temperature excursion. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 31-Aug-2022: Follow-up received included vaccine refrigeration date was updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive 2 months ago
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 94,0
- Geschlecht
- M
- Eingang
- 01.09.2022
- Impfdatum
- 15.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 4,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abnormal behaviour
Acute kidney injury
Bladder cancer
Bladder mass
COVID-19
Chronic kidney disease
Computerised tomogram head
Dementia Alzheimer's type
Femur fracture
Fracture treatment
Heart rate irregular
Hip arthroplasty
Hip fracture
Lethargy
Lymphadenopathy
Renal tubular necrosis
Ultrasound Doppler
Ventilation/perfusion scan
Symptomtext
Patient ID: Patient 94 y.o. Admit Date: 7/19/2022 Discharge Date: 7/25/2022 Discharge Diagnosis: Principal Problem: Subcapital fracture of femur, right, closed, initial encounter Active Problems: Late onset Alzheimer's disease with behavioral disturbance Acute renal failure with acute tubular necrosis superimposed on stage 3a chronic kidney disease History of deep venous thrombosis (DVT) of distal vein of left lower extremity Bladder mass COVID-19 virus infection Pelvic lymphadenopathy Invasive carcinoma of urinary bladder Hospital Course: 94 year old male resident of a nursing home was admitted for right hip fracture which was surgically repaired. He also ha Covid-19 infection and advancing bladder cancer. Family decided not to pursue further with treatment of the cancer. He also has acute renal failure. Family made him DNR and later comfort care after hip fracture was surgically repaired. He is lethargic and not in distress. He will be transferred back to the NH today in comfort care status. Physical Exam on the day of discharge: Last Recorded Vital Signs: Temp: 99.5 ?F (37.5 ?C) Heart Rate (Monitor): 65 Pulse: 72 BP: 137/90 Respirations: 16 SpO2: 96 % O2 Flow Rate (l/min): 2 l/min General Appearance: lethargic Eyes: PERRLA ENT: moist mucus membranes, no adenopathy Lungs: clear to auscultation bilaterally Heart: irregular rate and rhythm Abdomen: soft, non-tender Skin: No rashes or lesions Extremities: no edema Neuro: disoriented Consults: IP CONSULT TO ORTHOPEDIC IP CONSULT TO UROLOGY IP CONSULT TO NEPHROLOGY IP CONSULT TO SOCIAL WORK IP CONSULT TO SUPPORTIVE CARE SERVICES IP CONSULT TO SOCIAL WORK IP CONSULT TO SUPPORTIVE CARE SERVICES IP CONSULT TO SUPPORTIVE CARE SERVICES Significant Diagnostic Studies: CT head, BLE venous US, VQ scan Operations: Right hip hemiarthroplasty Disposition: SNF Discharge Condition: Poor
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abnormal behaviour
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- -
- Geschlecht
- M
- Eingang
- 31.08.2022
- Impfdatum
- 31.08.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient was given 2nd booster dose of covid moderna before the age of 50 and without any high risk concerns. No treatment at the time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 30.08.2022
- Impfdatum
- 18.07.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 15,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Aura
Vision blurred
Symptomtext
I had the vaccination 07/18/2022. On 08/02/2022 I started to experience a visual aura again. It was similar to blurry horizontal line that increased in blurriness and waviness for about an hour. After that hour, it disappeared. I did a telephone consult and Dr. stated to monitor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Aura
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Cholesterol; Eczema on elbows and scalp
- Andere Medikamente
- Pravastatin; ALLERTEC; L-carnitine; vitamin D; vitamin A (unknown)
- Allergien
- Ketoconazole
- Vorherige Impfungen
- COVID-19 second vaccination 05/04/2022 Visual Aura.
- Staat
- MI
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 29.08.2022
- Impfdatum
- 27.08.2022
- Beginn
- 29.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Patient was given an adult dose of Moderna Covid Vaccine (100mcg) when he should have been given Moderna 6-11year Vaccine (50mcg)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- None at this time.
- Aktuelle Erkrankungen
- Asthma Autism Spectrum Disorder
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Augmentin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 26.08.2022
- Impfdatum
- 24.08.2022
- Beginn
- 25.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 25.08.2022
- Impfdatum
- 25.08.2022
- Beginn
- 25.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hypoaesthesia oral
Symptomtext
After 15 min observation time from receiving the 1st dose of COVID19 moderna vaccine at 02:58pm on 8/25/22 pt stated feeling numbness in the mouth, water was given to pt drank w/o difficulty, spoke clearly without problem, A/O to time, place, and name. Pt vitals recorded at 3:07pm read BP-132/78, HR-106, RR-22, O2-98% on RA. pt observed for remaining 15 min vitals recorded again at 3:14pm BP-130/82, HR-104, RR-22, O2-99% on RA, pt stated a history of HTN and DM, stated currently taking medications pt stated BP runs a bit high even with medications, after a few min pt stated feeling better regained sensation of the mouth and last vitals recorded at 3:28pm BP-128/82, HR-98, RR-20, O2 sat-99% RA. pt stated feeling better and ok to drive, ER precautions provided with s/s of allergic reactions to observe, pt verbalized understanding.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypoaesthesia oral
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, DM Type 2, chronic back pain
- Andere Medikamente
- loratadine 10mg, Aspirin, Semaglutide, Jardiance 25mg
- Allergien
- Iodine, penicillin
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 22.08.2022
- Impfdatum
- 16.08.2022
- Beginn
- 16.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient was brought to health center by parent for COVID booster. Patient had previously had 2 Pfizer doses. Moderna 0.25mL dose was given to patient. It was later realized that Moderna is not yet approved by CDC for booster in patients under the age of 18. Patient parent was notified and voiced no concerns at this time. Additional training, education and information sheets were provided to all staff at health center to prevent future errors.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 18.08.2022
- Impfdatum
- 17.08.2022
- Beginn
- 17.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Resident got Moderna Booster 0.25ml, however she had the booster on 6/9/22 and on 12/2/21, making this her 3rd Booster
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cerebral palsy, Tremor, Hypertension, Polyosteoarthritis, Hyperlipidemia, GERD, Hypothyroidism,
- Andere Medikamente
- Sertraline, Gabapentin, Levothyroxine, Famotidine, Alendronate, Senna, Vit D, Melatonin, Norco, Klonopin,
- Allergien
- Antihistamine
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 16.08.2022
- Impfdatum
- 11.08.2022
- Beginn
- 11.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient received second booster dose (0.25 ml) of Moderna COVID-19 but later found not to have immunological disorder that would make him eligible to receive the booster dose. No adverse reaction to the vaccine was reported by the patient. Manufacturer was contacted regarding this occurance but no specific guidance was provided aside from ensuring patient does not receive an additional dose of the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 16.08.2022
- Impfdatum
- 22.01.2021
- Beginn
- 21.06.2022
- Tage bis Beginn
- 515,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Symptomtext
Admitted to the hospital with COVID-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anxiety, Arrhythmia, Arthritis, Asthma, Cataract, CHF (congestive heart failure), Chronic kidney disease, Community acquired pneumonia, COPD (chronic obstructive pulmonary disease), COVID-19 (06/14/2022), Depression, Diabetes mellitus, Fall, GERD (gastroesophageal reflux disease), Hernia, abdominal, Hiatal hernia, OTHER MEDICAL, Hyperlipidemia, Hypertension, Morbid obesity (BMI 40.0 or higher), Osteoporosis, Seasonal allergies, Thyroid disease, UTI (urinary tract infection), Wears dentures, and WPW syndrome
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 13.08.2022
- Impfdatum
- 30.07.2022
- Beginn
- 30.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
Rehab facility patient under the age of 50 and not known to be immunocompromised was given a second booster shot.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vial was initially stored in the refrigerator on 8-Jul-2022 and was administered on 9-Aug-2022; No adverse event; Expired dose administered to patient 2 days after use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient 2 days after use by date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 8-Jul-2022 and was administered on 9-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Aug-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient 2 days after use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 8-Jul-2022 and was administered on 9-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient 2 days after use by date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 8-Jul-2022 and was administered on 9-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient 2 days after use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 8-Jul-2022 and was administered on 9-Aug-2022). No concomitant medications were reported. The patient had not reported any adverse reactions to this dose. The vial was initially stored in the refrigerator on 8-Jul-2022. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 10.08.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Vaccination error
Wrong product administered
Symptomtext
Mother asked for Pfizer vaccine however Moderna was inadvertently administered. Both mother and patient were advised of the error immediately after vaccination was given. The correct dose of Moderna was given to the patient and she had no adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 09.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Given second booster shot outside of protocol - no adverse events reported by patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 07.08.2022
- Impfdatum
- 05.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Underdose
Symptomtext
Client presented to the vaccination site on 08/05/2022 for her Moderna COVID vaccine. Today, the client consented to receive Moderna COVID booster dose #1 (0.25 ml) (Lot #: 006M21A exp: 08/19/22). After reviewing the vaccination forms, worker noted that client never receive any primary series which means she is under dose today since the client received administration of the Moderna COVID booster #1 instead of a first dose Moderna COVID vaccine (full dose 0.5 ml). worker notified supervisor. supervisor submitted a medical consult via text message to the doctor, requesting for guidance on how to proceed. supervisor received recommendation from the doctor with recommendation to call client to come back today (8/5/22) or tomorrow for the Moderna COVID booster dose #2 to complete the recommended first dose Moderna COVID vaccine of 0.5 ml. supervisor called client to inform her of the doctor's recommendation for her to come back for her Moderna COVID booster dose #2 to complete the recommended first dose Moderna COVID vaccine (full dose of 0.5 cc). Client said to supervisor that she cannot come back until after four weeks. supervisor sent a follow-up text message to the doctor informing him that client cannot come back until after four weeks. supervisor received a text message from the doctor that the recommendation should be for client return today or tomorrow, and if the client decline or cannot come back then nothing can be done today. supervisor unable to educate client on the side effects of Moderna COVID vaccine since client left the vaccination site before the under dose of Moderna COVID vaccine given was noted and unable to obtain any information if client has any chronic conditions, current medications, or known allergies. supervisor educated on confirming with each client the right client, right vaccine, right dose/time frame, and any history of adverse reactions or known allergies in the future.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 07.08.2022
- Impfdatum
- 05.08.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Underdose
Symptomtext
Client presented to the vaccination site on 08/05/2022 for his Moderna COVID vaccine. Today, the client consented to receive Moderna COVID booster dose #1 (0.25 ml) (Lot #: 006M21A exp: 08/19/22) by LVN. After reviewing the vaccination forms, Staff worker noted that client never receive any primary series which means he is under dose today since the client received administration of the Moderna COVID booster dose #1 instead of a first dose Moderna COVID vaccine (full dose 0.5 ml). Staff worker notified PHN supervisor. PHN supervisor submitted a medical consult via text message to the doctor, requesting for guidance on how to proceed. PHN supervisor received recommendation from the doctor with recommendation to call client to come back today (8/5/22) or tomorrow for the Moderna COVID booster dose #2 to complete the recommended first dose Moderna COVID vaccine of 0.5 ml. PHN supervisor called client to inform him of the doctor?s recommendation for him to come back for his Moderna COVID booster dose #2 to complete the recommended first dose Moderna COVID vaccine (full dose of 0.5 cc). PHN supervisor left a message for client to call back since client did not answer his phone. PHN supervisor sent a follow-up text message to the doctor informing him that client did not answer his phone and left him a message for him to call her back. PHN supervisor received a text message from the doctor that the recommendation should be for client return today or tomorrow, and if the client did not answer his phone, then nothing can be done today. PHN supervisor unable to educate client on the side effects of Moderna COVID vaccine since client left the vaccination site before the under dose of Moderna COVID vaccine given was noted and unable to obtain any information if client has any chronic conditions, current medications, or known allergies. PHN supervisor educated LVN on confirming with each client the right client, right vaccine, right dose/time frame, and any history of adverse reactions or known allergies in the future. PHN supervisor notified the PHN lead for the medical Team on 8/7/22, Sunday to call client again to inform client to return 8/7/22, Sunday to receive the Moderna COVID booster dose #2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 06.08.2022
- Impfdatum
- 15.07.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 7,0
- Dosis
- 4
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test
Vaccination failure
Symptomtext
This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for Covid-19) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. Prior to vaccination patient was not diagnosed with COVID-19. Previously administered products included for Product used for unknown indication: Pfizer (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Right Arm, Route of Administration: Intramuscular.) on 01-Feb-2021, Pfizer (Dose Number: 2, Batch/Lot No: Unknown, Location of injection: Left Arm, Route of Administration: Intramuscular) on 20-Feb-2021, Pfizer (Dose Number: 3, Batch/Lot No: FC3183, Location of injection: Right Arm and Route of Administration: Intramuscular) on 24-Sep-2021. Past adverse reactions to the above products included No adverse reaction with Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Allergy (Name of Drug as Reported as no). On 15-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (tested positive for Covid-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (tested positive for Covid-19) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jul-2022, SARS-CoV-2 test: (Positive) Positive. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. There were list of other medications the patient received within 2 weeks of vaccination (unspecified). Company Comment: This is a spontaneous case concerning a 43-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious adverse event of special interest COVID-19, supported by a positive SARS-CoV-2 test, which occurred 7 days after receiving a dose of mRNA-1273 as the fourth dose of COVID-19 vaccine. Patient had received 3 doses of Pfizer COVID-19 vaccine with no reported adverse event, approximately 9 months and 3 weeks prior to mRNA-1273 vaccination (Interchange of vaccine products). The patient was treated with Nirmatrelvir/ Ritonavir (Paxlovid) for COVID-19, at an unspecified dose and frequency. No further details about the clinical course was provided. It was reported that the event was resolving. The benefit-risk relationship of mRNA-1273 is not affected by this report. Sender's Comments: This is a spontaneous case concerning a 43-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious adverse event of special interest COVID-19, supported by a positive SARS-CoV-2 test, which occurred 7 days after receiving a dose of mRNA-1273 as the fourth dose of COVID-19 vaccine. Patient had received 3 doses of Pfizer COVID-19 vaccine with no reported adverse event, approximately 9 months and 3 weeks prior to mRNA-1273 vaccination (Interchange of vaccine products). The patient was treated with Nirmatrelvir/ Ritonavir (Paxlovid) for COVID-19, at an unspecified dose and frequency. No further details about the clinical course was provided. It was reported that the event was resolving. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220722; Test Name: COVID-19 test; Test Result: Positive; Result Unstructured Data: Positive.
- Aktuelle Erkrankungen
- Allergy (Name of Drug as Reported as no)
- Vorgeschichte
- Comments: Prior to vaccination patient was not diagnosed with COVID-19.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 03.08.2022
- Impfdatum
- 03.08.2022
- Beginn
- 03.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
Patient came into the clinic, providing his name, and that he was on his first dose. After verifying in database with the name provided, no record of COVID-19 vaccine was found so a 1st dose of Moderna was given. When filling out the incentive form, which requires a signature, he signed his real name. We verified with database to see if that name had a vaccine record. It was found that he had two records. Both records had a history of COVID-19 vaccination. He had previously received Pfizer doses on 01/25/2022, 02/16/2022 and 03/01/2022, making his dose today, his 4th mRNA vaccine. No signs and symptoms were noted during his 15 minutes of monitoring and he left the clinic without any complaints.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NO KNOWN DRUG ALLERGIES
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 02.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
No adverse event
Symptomtext
NO ADVERSE EVENT to report. Administration error. Patient requested a "booster" of Moderna online through the app and then verified upon review on information with patient. He did not have his vaccination records with him. A booster dose of 0.25ml was given in right deltoid. After injection during the waiting period he said that he had only received 1 previous covid vaccination (moderna) which was found to be March 2021. Verified through local registry. The patient was then given a second 0.25ml dose in the opposite arm (left deltoid) to complete the 0.5ml dose needed for his second vaccination. So technically an administration error for 2nd dose, but it was corrected immediately with the patient. No adverse events to report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 01.08.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Underdose
Symptomtext
No adverse event occurred. This is being reported because the incorrect booster dosage of 0.25 ml was administered rather than the initial vaccine dosage of 0.5 ml. Pharmacy and physician recommends giving the additional 0.25 ml of vaccine to equal the complete dose of the initial vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No illness
- Vorgeschichte
- COPD, Back/leg pain, GERD, Hyperlipidemia, CHF, Compression Fracture
- Andere Medikamente
- Hydroxyzine, Aspirin, Bumex, Digoxin, Docusate Sodium, Flomax, Folic Acid, Gabapentin, Magnesium Oxide, Potassium Chloride, Singulair, Spironolactone, Thiamine, Morphine Sulfate,
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 30.07.2022
- Impfdatum
- 27.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Lymphadenopathy
Symptomtext
Swollen lymph node in armpit and neck area
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lymphadenopathy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Omeprazole, Cymbalta, Avorstatin
- Allergien
- Penicillin, Sulfa, Erythromycin
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient's age made her ineligible for the 2nd booster she received.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 28.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
Pt. was given 0.25ml of moderna vaccine instead of the 0.5ml. Pt. was monitored for adverse reactions for 15 minutes. No signs or symptom noted and released.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Tooth Decay and extration
- Vorgeschichte
- Dermatitis Tardive Dyskinesia Schizoaffective D.O.
- Andere Medikamente
- Aspirin 81mg 1qd Betamethasone Cream 0.5% Apply topically to affected area as needed Depakote 500mg 1qam Ativan 1mg po bid Depakote 750mg Qhs Haldol Dec 150mg IM Q 4 weeks
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- -
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
realized after the fact it was a little past 24 hours sitting out/Dose administered after exposure to room temperature more than 24 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (realized after the fact it was a little past 24 hours sitting out/Dose administered after exposure to room temperature more than 24 hours) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (realized after the fact it was a little past 24 hours sitting out/Dose administered after exposure to room temperature more than 24 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (realized after the fact it was a little past 24 hours sitting out/Dose administered after exposure to room temperature more than 24 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications was not provided by the reporter. Patient accidently got a Moderna booster vaccine on 21-Jul-2022. On 16-JUL-2022,the vial was initially stored in the refrigerator. The vial doesn't undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8 degree to 25 degree Celsius = 46 degree to 77 degree Fahrenheit) 25 or 26 hours. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Punctured vial stored in the refrigerator more than 24 hours; Received expired first primary dose beyond 12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired first primary dose beyond 12 hours post puncture) and PRODUCT STORAGE ERROR (Punctured vial stored in the refrigerator more than 24 hours) in a 38-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jul-2022 at 9:30 AM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-Jul-2022, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired first primary dose beyond 12 hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Punctured vial stored in the refrigerator more than 24 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired first primary dose beyond 12 hours post puncture) and PRODUCT STORAGE ERROR (Punctured vial stored in the refrigerator more than 24 hours) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Date the vial was initially stored in the refrigerator on 13-JUL-2022. Date and Time when the vial was first punctured on 20-JUL-2022 at 07:45 AM. The vial was in the refrigerator post puncture for 24 hours. The vial did not undergo any temperature excursions. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 20.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
C-reactive protein increased
Vaccination site erythema
Vaccination site induration
Vaccination site warmth
Symptomtext
Patient had red area around vaccine. By today it was red, warm to touch in a 6" by 3" area, hard to touch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- C-reactive protein increased
- Hospital-Tage
- -
- Labordaten
- CRP lab high per patient.
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- diabetes, blood cancer in remission
- Andere Medikamente
- metformin at noon other meds am and pm
- Allergien
- penicillin
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 20.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Swelling
Symptomtext
Right arm pit swelling
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Losartan
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 22.07.2022
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patient was accidently given a Moderna dose that was approx 1-2 hours past the expiration date of being at room tempature.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HIV +, Hepatitus C, Hyperlipidemia,
- Andere Medikamente
- Zolpidem 10mg, Lisinopril 5mg, Rosuvastatin 10mg, Eliquis 5mg,
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 21.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Product administered to patient of inappropriate age
Symptomtext
This age group (12to 18yo) is not approved for a booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 21.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
This vaccine is not approved as a booster for this age group.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 20.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Exposure during pregnancy
Underdose
Symptomtext
Patient came in to get a 2nd dose of her Moderna vaccine but instead of getting a full dose (0.5 mL), she got the booster dose (0.25 mL). She is approximately 4 months pregnant. She didn't have any adverse reactions to the vaccine and she left the vaccine clinic after waiting her 15 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- None
- Andere Medikamente
- Unknown
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 20.07.2022
- Impfdatum
- 20.07.2022
- Beginn
- 20.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Vaccine given when not indicated. Referenced outdated COVID vaccine administration paper that stated as follow, " 2nd Covid Booster is 4 months after 1st booster." No age requirement present, gave pt 2nd booster and she is 38 years old. Only indicated in patient greater than 50. Having no adverse reaction or symptoms at this time. Provider made aware of mistake and correct actions taken toward management of issue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Viibryd, Myrbetriq
- Allergien
- Diflucan
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
No adverse event
Symptomtext
second COVID19 booster approximately 2 months early, no adverse events
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- HYPERTENSION
- Andere Medikamente
- LOSARTAN 50MG AMLODIPINE VITAMINS
- Allergien
- NO KNOWN ALLERGIES
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 18.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Inappropriate schedule of product administration
No adverse event
Symptomtext
Patient received a 3rd booster vaccine. Received 1st booster (0.25 mL) in 10/2021, then received a 2nd booster in 4/2022, and received a 3rd booster on 7/18/22. Experienced no side effects from any of the vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Losartan 100, Omeprazole 20, Zolpidem 5
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Gave Moderna to a 12 year old instead of Pfizer
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 17.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 15.07.2022
- Beginn
- 15.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
A floater left a vial of moderna overnight and a dose was drawn from a vial that had been punctured > 12 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Inappropriate schedule of product administration
Symptomtext
Pt received 2nd booster too soon, before 4months. Pt had no adverse events. Pt received first booster on 4/15/22 and 2nd booster on 7/13/22. Pt did not bring card so staff had to call pharmacy for information. Not sure if person reciting previous doses or person writing it down missed mentioning that pt has gotten 1st booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 14.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Sensitive skin
Symptomtext
skin sensitivity started in injection arm moved to upper body. still ongoing, not likely to seek medical attention.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Sensitive skin
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Descovy for Prep
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 13.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Throat irritation
Symptomtext
Patient said his throat felt "scratchy" a couple of minutes after administration of vaccine. He drank some water and he received 25mg Benadryl. He refused to stay for further observation after 13 minutes from administration and he and his wife decided to leave. He danced a few steps to prove he was fine and left. I called him today and he said he's perfectly fine and that he was very nervous of needles. NOTE: Patient never showed visible symptoms of an anaphylactic reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Throat irritation
- Hospital-Tage
- -
- Labordaten
- NONE applicable as patient is fine
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- F
- Eingang
- 21.08.2021
- Impfdatum
- 27.02.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 33,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dysphonia
Symptomtext
Voice is hoarse; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (Voice is hoarse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0037217 and 006M21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSPHONIA (Voice is hoarse). At the time of the report, DYSPHONIA (Voice is hoarse) outcome was unknown. Not Provided Concomitant medications was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dysphonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 13.02.2021
- Beginn
- 13.03.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Multiple sclerosis
SARS-CoV-2 antibody test
Symptomtext
Very weak for about a week "worsening of multiple sclerosis"; Very weak for about a week; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MULTIPLE SCLEROSIS (Very weak for about a week "worsening of multiple sclerosis") in a 74-year-old male patient who received mRNA-1273 (batch nos. 001B21A and 006M21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Multiple sclerosis. Concomitant products included WARFARIN, METOPROLOL, OXYBUTYNIN and LEVOTHYROXINE for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced MULTIPLE SCLEROSIS (Very weak for about a week "worsening of multiple sclerosis") (seriousness criteria medically significant) and ASTHENIA (Very weak for about a week). On 20-Mar-2021, MULTIPLE SCLEROSIS (Very weak for about a week "worsening of multiple sclerosis") had resolved. At the time of the report, ASTHENIA (Very weak for about a week) outcome was unknown. Unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) Negative. No treatment medications were reported. The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- -
- Labordaten
- Test Name: COVID-19 antibody test; Test Result: Negative ; Result Unstructured Data: Negative
- Aktuelle Erkrankungen
- Multiple sclerosis
- Vorgeschichte
- -
- Andere Medikamente
- WARFARIN; METOPROLOL; OXYBUTYNIN; LEVOTHYROXINE
- Allergien
- -
- Vorherige Impfungen
- -